<SEC-DOCUMENT>0001493152-22-003277.txt : 20220204
<SEC-HEADER>0001493152-22-003277.hdr.sgml : 20220204
<ACCEPTANCE-DATETIME>20220204165952
ACCESSION NUMBER:		0001493152-22-003277
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20220204
DATE AS OF CHANGE:		20220204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEA Industries Inc.
		CENTRAL INDEX KEY:			0001482541
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE SERVICES [0700]
		IRS NUMBER:				273911608
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-261648
		FILM NUMBER:		22594306

	BUSINESS ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-993-5271

	MAIL ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Surna Inc.
		DATE OF NAME CHANGE:	20100128
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SRNA="http://surna.com/20210930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_SRNA_surna.com_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20210101_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001482541 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentType_S%2D1/A -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityCentralIndexKey">0001482541</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="srna-20210930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
filed with the Commission on February 4, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
No. 333-261648</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--AmendmentDescription_c20210101__20210930_zJSsx3P7z59i"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:AmendmentDescription">AMENDMENT
NO. 2</ix:nonNumeric></span> TO</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
S-1</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNDER<br />
THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_904_edei--EntityRegistrantName_c20210101__20210930_z4JOByVvkLP5"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityRegistrantName">CEA
Industries Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(formerly
known as Surna Inc.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20210101__20210930_zsf8tJ4DVeW2"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>0700</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20210101__20210930_zNeKfJvvcYEa"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityTaxIdentificationNumber">27-3911608</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    Standard Industrial</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
    Code Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20210101__20210930_zdoZMhTYSwgd"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine1">385
South Pierce Avenue</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20210101__20210930_zUjgK66b8Wr5"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine2">Suite C</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressCityOrTown_c20210101__20210930_zj8ARfL0eVXg"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressCityOrTown">Louisville</ix:nonNumeric></span>,
<span id="xdx_902_edei--EntityAddressStateOrProvince_c20210101__20210930_zFCfkr4QL7ik"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Colorado</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20210101__20210930_zZq4bWbRUdGf"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressPostalZipCode">80027</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--CityAreaCode_c20210101__20210930_zOebtLWxipxd"><span><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:CityAreaCode">(303)</ix:nonNumeric></span>
<span id="xdx_903_edei--LocalPhoneNumber_c20210101__20210930_zNztMNMDWVjf"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:LocalPhoneNumber">993-5271</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anthony
K. McDonald</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA
Industries Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>385
South Pierce Avenue, Suite C</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Louisville,
Colorado 80027<br />
(303) 993-5271</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Copies
to:</i></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Andrew
    Hudders, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Golenbock
    Eiseman Assor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bell
    &amp; Peskoe LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>711
    Third Avenue, 17th Floor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, NY 10017</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(212)
    907-7300</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rob
    Condon, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dentons
    US LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1221
    Avenue of the Americas</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, NY 10020</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(212)
    768-6700</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale to the public: </b>As soon as practicable after this registration statement becomes effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityFilerCategory_c20210101__20210930_zyTtQT7Ot7E1"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_900_edei--EntitySmallBusiness_c20210101__20210930_zbY7zHo7zPOk"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20210101__20210930_zo6Dckz25Rg8"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CALCULATION
OF REGISTRATION FEE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Title of each class of securities to be registered(1)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proposed<br /> maximum aggregate<br /> offering price (2)(3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount of<br /> registration fee</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%">Common Stock, par value $0.00001 per share</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">23,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,132.10</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Warrants to purchase shares of Common Stock, par value $0.00001 per share(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Pre-funded warrants to purchase shares of Common Stock, par value $0.00001 per share(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Shares of Common Stock, par value $0.00001 per share, underlying the warrants(5)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">28,750,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,665.13</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Shares of Common Stock, par value $0.00001 per share, underlying the pre-funded warrants(6)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,132.10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants to be issued to the representative of the underwriters(4)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock underlying warrants to be issued to the representative of the underwriters(7)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,437,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">133.26</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Total:</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">76,187,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,062.59</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Registration Fee Previously Paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,062.59</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.3pt; text-align: justify; text-indent: -22.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), there are also being registered such
    indeterminate number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or
    similar transactions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. Includes the offering
    price of any additional shares of common stock, pre-funded warrants and warrants that the underwriters have the right to purchase
    to cover over-allotments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    proposed maximum aggregate offering price of shares of common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar
    basis based on the offering price of any pre-funded warrants offered and sold in the offering, and the proposed maximum aggregate
    offering price of the pre-funded warrants to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering
    price of any shares of common stock sold in the offering. Accordingly, the proposed maximum aggregate offering price of the shares
    of common stock and pre-funded warrants (including the shares of common stock issuable upon exercise of the pre-funded warrants),
    if any, is $23,000,000.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    registration fee required pursuant to Rule 457(g).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    warrants are exercisable at a price per share of common stock equal to 125% of the common stock offering price.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    pre-funded warrants are exercisable at an exercise price of $0.01 per share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have agreed to issue to the representative of the underwriters warrants to purchase shares of common stock representing up to 5%
    of the common stock and pre-funded warrants issued in the offering. The representative&#8217;s warrants are exercisable at a per
    share exercise price equal to 125% of the public offering price per share of the common stock offered hereby. As estimated solely
    for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate
    offering price of the representative&#8217;s warrants is $1,437,500, which is equal to 125% of $1,150,000 (5% of $23,000,000). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date
as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPLANATORY
NOTE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
Industies Inc. is filing this Amendment No. 2 to its registration statement on Form S-1 (the &#8220;Registration Statement&#8221;) as
an exhibits-only filing. Accordingly, this amendment consists only of the facing page, this explanatory note, Item 16 of Part II of the
Registration Statement, and the filed exhibits. The remainder of the Registration Statement is unchanged and has therefore been omitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
    16.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits
    and Financial Statement Schedules</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exhibits. We have filed the exhibits listed on the accompanying Exhibit Index of this Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.7in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
    *</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1-1.htm">Form
    of Underwriting Agreement</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(a)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh31.htm" style="-sec-extract: exhibit">Articles
    of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Registration Statement on Form S-1 as filed on January 28,
    2010).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(b)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-1b.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation (incorporated herein by reference to Exhibit 3.1(b) to the Annual Report on Form 10-K filed April 2,
    2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(c)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315214001395/ex3-2.htm" style="-sec-extract: exhibit">Certificate
    of Designations of Preferences, Rights, and Limitations of Preferred Stock (incorporated herein by reference to Exhibit 3.2 to the
    Current Report on Form 8-K as filed on May 12, 2014).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(d)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex3-1.htm" style="-sec-extract: exhibit">Certificate
    of Designations of Preferences, Rights, and Limitations of Class B Preferred Stock (incorporated herein by reference to Exhibit 3.1
    to the Current Report on Form 8-K as filed on September 30, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(e)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221027175/ex3-1.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation to increase capitalization and redeem Class A Preferred Stock (incorporated herein by reference to Exhibit
    3.1 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(f)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221029245/ex3-1.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation to change corporate name (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form
    8-K filed November 12, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(g)**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex3-1.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation to effect a reverse split and fix capitalization.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-2.htm" style="-sec-extract: exhibit">Bylaws,
    as amended (incorporated herein by reference to Exhibit 3.2 to the Annual Report on Form 10-K filed April 2, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh41.htm" style="-sec-extract: exhibit">Specimen
    Stock Certificate (incorporated herein by reference to Exhibit 4.1 to the Registration Statement on Form S-1 filed on January 28,
    2010).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221006659/ex4-7.htm" style="-sec-extract: exhibit">Description
    of Securities (incorporated herein by reference to Exhibit 4.7 to the Annual Report on Form 10-K filed March 24, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
    *</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-3.htm">Form
    of the Underwriter Representative Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-3.htm" style="-sec-extract: exhibit">Form
    of Investor Warrant Agreement, dated as of September 28, 2021 (incorporated herein by reference to Exhibit 10.3 to the Current Report
    on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-6.htm" style="-sec-extract: exhibit">Form
    of Placement Agent Warrant Agreement, dated as of September 28, 2021, by and between Surna Inc and ThinkEquity and designees (incorporated
    herein by reference to Exhibit 10.6 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex4-6.htm" style="-sec-extract: exhibit">Form
    of Warrant Agency Agreement for the Investor Warrants.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex4-6.htm" style="-sec-extract: exhibit">Form
    of Warrant (included in Exhibit 4.6).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex4-8.htm" style="-sec-extract: exhibit">Form
    of Pre-Funded Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex5-1.htm" style="-sec-extract: exhibit">Opinion
    of Golenbock Eiseman Assor Bell &amp; Peskoe LLP.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
    #</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221029932/ex10-1.htm" style="-sec-extract: exhibit">Executive
    Employment Agreement between the Company and Anthony K. McDonald dated effective November 24, 2021 (incorporated herein by reference
    to Exhibit 10.1 to the Current Report on Form 8-K filed November 26, 2021).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
    #</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221015205/ex10-1.htm" style="-sec-extract: exhibit">Executive
    Employment Agreement between the Company and Brian Knaley, dated June 28, 2021 (incorporated herein by reference to Exhibit 10.1
    to the Current Report on Form 8-K filed June 24, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315217008485/ex99-1.htm" style="-sec-extract: exhibit">Surna
    Inc. 2017 Equity Incentive Plan (incorporated herein by reference to Exhibit 99.1 to the Registration Statement on Form S-8 filed
    on August 3, 2017)</a>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221008188/def14a.htm" style="-sec-extract: exhibit">Surna
    Inc. 2021 Equity Incentive Plan (incorporated herein by reference to Exhibit B to the Proxy Statement of the Registrant, for the
    annual meeting to be held May 28, 2021 filed on April 7, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.7in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-2.htm" style="-sec-extract: exhibit">Stock
    Repurchase Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference
    to Exhibit 10.2 to the Current Report on Form 8-K filed May 31, 2018)</a>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-3.htm" style="-sec-extract: exhibit">Preferred
    Stock Option Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference
    to Exhibit 10.3 to the Current Report on Form 8-K filed May 31, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-1.htm" style="-sec-extract: exhibit">Form
    of Securities Purchase Agreement, dated as of September 28, 2021, by and between Surna Inc. and the institutional investor (incorporated
    herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-2.htm" style="-sec-extract: exhibit">Form
    of Registration Rights Agreement, dated as of September 28, 2021, by and between Surna Inc. and the institutional investor (incorporated
    herein by reference to Exhibit 10.2 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218002044/ex14.htm" style="-sec-extract: exhibit">Form
    of Placement Agent Agreement, dated as of September 28, 2021, by and between Surna Inc. and ThinkEquity (incorporated herein by reference
    to Exhibit 10.5 to the Current Report on Form 8-K filed November 4, 2021).14.1 Code of Business Code and Ethics adopted February
    13, 2018 (incorporated herein by reference to Exhibit 14 to the Current Report on Form 8-K filed February 14, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221006659/ex21-1.htm" style="-sec-extract: exhibit">Subsidiaries
    (incorporated herein by reference to Exhibit 21,1 to the Annual Report on Form 10-K filed March 24, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex23-1.htm" style="-sec-extract: exhibit">Consent
    of (ACM LLP) Independent Registered Public Accounting Firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex23-2.htm" style="-sec-extract: exhibit">Consent
    of Sadler, Gibb &amp; Associates, L.L.C. , Independent Registered Public Accounting Firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex5-1.htm" style="-sec-extract: exhibit">Consent
    of Golenbock Eiseman Asssor Bell &amp; Peskoe LLP (incorporated by reference to Exhibit 5.1 of this Registration Statement, in which
    it is included)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/forms-1a.htm#a_001" style="-sec-extract: exhibit">Power
    of Attorney (included on signature page of this Form S-1).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS**
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instances Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denotes
    a management contract or compensatory plan or arrangement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed by amendment</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<i>Financial Statement Schedules</i>. All financial statement schedules are omitted because the information called for is not required
or is shown either in the consolidated financial statements or in the notes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement on Form S-1
to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Louisville, State of Colorado, on the 4th day
of February 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA
    INDUSTRIES INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Anthony K. McDonald</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities
and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Anthony K. McDonald</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    4, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Brian Knaley</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    4, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Knaley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    4, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    R. Shipley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    4, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
    J. Etten</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    4, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marion
    Mariathasan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    4, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troy
    L. Reisner</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 3%">By</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Power of Attorney</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>By
    </td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Anthony K. McDonald</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony K. McDonald</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.7in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
    *</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex1-1.htm">Form
    of Underwriting Agreement</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(a)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh31.htm" style="-sec-extract: exhibit">Articles
    of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Registration Statement on Form S-1 as filed on January 28,
    2010).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(b)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-1b.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation (incorporated herein by reference to Exhibit 3.1(b) to the Annual Report on Form 10-K filed April 2,
    2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(c)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315214001395/ex3-2.htm" style="-sec-extract: exhibit">Certificate
    of Designations of Preferences, Rights, and Limitations of Preferred Stock (incorporated herein by reference to Exhibit 3.2 to the
    Current Report on Form 8-K as filed on May 12, 2014).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(d)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex3-1.htm" style="-sec-extract: exhibit">Certificate
    of Designations of Preferences, Rights, and Limitations of Class B Preferred Stock (incorporated herein by reference to Exhibit 3.1
    to the Current Report on Form 8-K as filed on September 30, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(e)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221027175/ex3-1.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation to increase capitalization and redeem Class A Preferred Stock (incorporated herein by reference to Exhibit
    3.1 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(f)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221029245/ex3-1.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation to change corporate name (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form
    8-K filed November 12, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(g)**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex3-1.htm" style="-sec-extract: exhibit">Amendment
    to Articles of Incorporation to effect a reverse split and fix capitalization.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-2.htm" style="-sec-extract: exhibit">Bylaws,
    as amended (incorporated herein by reference to Exhibit 3.2 to the Annual Report on Form 10-K filed April 2, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh41.htm" style="-sec-extract: exhibit">Specimen
    Stock Certificate (incorporated herein by reference to Exhibit 4.1 to the Registration Statement on Form S-1 filed on January 28,
    2010).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221006659/ex4-7.htm" style="-sec-extract: exhibit">Description
    of Securities (incorporated herein by reference to Exhibit 4.7 to the Annual Report on Form 10-K filed March 24, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
    *</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-3.htm">Form
    of the Underwriter Representative Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-3.htm" style="-sec-extract: exhibit">Form
    of Investor Warrant Agreement, dated as of September 28, 2021 (incorporated herein by reference to Exhibit 10.3 to the Current Report
    on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-6.htm" style="-sec-extract: exhibit">Form
    of Placement Agent Warrant Agreement, dated as of September 28, 2021, by and between Surna Inc and ThinkEquity and designees (incorporated
    herein by reference to Exhibit 10.6 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex4-6.htm" style="-sec-extract: exhibit">Form
    of Warrant Agency Agreement for the Investor Warrants.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex4-6.htm" style="-sec-extract: exhibit">Form
    of Warrant (included in Exhibit 4.6).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex4-8.htm" style="-sec-extract: exhibit">Form
    of Pre-Funded Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex5-1.htm" style="-sec-extract: exhibit">Opinion
    of Golenbock Eiseman Assor Bell &amp; Peskoe LLP.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1
    #</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221029932/ex10-1.htm" style="-sec-extract: exhibit">Executive
    Employment Agreement between the Company and Anthony K. McDonald dated effective November 24, 2021 (incorporated herein by reference
    to Exhibit 10.1 to the Current Report on Form 8-K filed November 26, 2021).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
    #</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221015205/ex10-1.htm" style="-sec-extract: exhibit">Executive
    Employment Agreement between the Company and Brian Knaley, dated June 28, 2021 (incorporated herein by reference to Exhibit 10.1
    to the Current Report on Form 8-K filed June 24, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315217008485/ex99-1.htm" style="-sec-extract: exhibit">Surna
    Inc. 2017 Equity Incentive Plan (incorporated herein by reference to Exhibit 99.1 to the Registration Statement on Form S-8 filed
    on August 3, 2017)</a>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221008188/def14a.htm" style="-sec-extract: exhibit">Surna
    Inc. 2021 Equity Incentive Plan (incorporated herein by reference to Exhibit B to the Proxy Statement of the Registrant, for the
    annual meeting to be held May 28, 2021 filed on April 7, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.7in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-2.htm" style="-sec-extract: exhibit">Stock
    Repurchase Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference
    to Exhibit 10.2 to the Current Report on Form 8-K filed May 31, 2018)</a>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-3.htm" style="-sec-extract: exhibit">Preferred
    Stock Option Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference
    to Exhibit 10.3 to the Current Report on Form 8-K filed May 31, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-1.htm" style="-sec-extract: exhibit">Form
    of Securities Purchase Agreement, dated as of September 28, 2021, by and between Surna Inc. and the institutional investor (incorporated
    herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-2.htm" style="-sec-extract: exhibit">Form
    of Registration Rights Agreement, dated as of September 28, 2021, by and between Surna Inc. and the institutional investor (incorporated
    herein by reference to Exhibit 10.2 to the Current Report on Form 8-K filed November 4, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218002044/ex14.htm" style="-sec-extract: exhibit">Form
    of Placement Agent Agreement, dated as of September 28, 2021, by and between Surna Inc. and ThinkEquity (incorporated herein by reference
    to Exhibit 10.5 to the Current Report on Form 8-K filed November 4, 2021).14.1 Code of Business Code and Ethics adopted February
    13, 2018 (incorporated herein by reference to Exhibit 14 to the Current Report on Form 8-K filed February 14, 2018).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221006659/ex21-1.htm" style="-sec-extract: exhibit">Subsidiaries
    (incorporated herein by reference to Exhibit 21,1 to the Annual Report on Form 10-K filed March 24, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex23-1.htm" style="-sec-extract: exhibit">Consent
    of (ACM LLP) Independent Registered Public Accounting Firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex23-2.htm" style="-sec-extract: exhibit">Consent
    of Sadler, Gibb &amp; Associates, L.L.C. , Independent Registered Public Accounting Firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315222002747/ex5-1.htm" style="-sec-extract: exhibit">Consent
    of Golenbock Eiseman Asssor Bell &amp; Peskoe LLP (incorporated by reference to Exhibit 5.1 of this Registration Statement, in which
    it is included)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1
    **</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
    of Attorney (included on signature page of this Form S-1).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS**
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instances Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denotes
    a management contract or compensatory plan or arrangement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed by amendment</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZi6ahLuzSoiJWkSLiNtipBNtMmaRVj+QtjS3iMDAM/7//hZiIDa1NjQyXZZHDCZu21h6hwAoZ7RWDI9vuUgi3wJtxnrX1w/sDMwoMBmY+jZUOwmDtjcMyBalmMpkpBTJJkwUc9yL66hnZypRovdE1aFvCkallg17za0w46SdZal5D1RnZGbIpxFM5ym9QMlZwoF4/iO8O8jwT0WSYSGyYuvZb0zlPDaxqbEKXG9H/Rh8YBUlK -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>between</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CEA
INDUSTRIES INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THINKEQUITY
LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>as
Representative of the Several Underwriters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CEA
INDUSTRIES INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>UNDERWRITING
AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
[&nbsp;&nbsp;], 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Representative of the several Underwriters named on Schedule 1 attached hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 22<SUP>nd</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, CEA Industries Inc., a corporation formed under the laws of the State of Nevada (collectively with its subsidiaries and
affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined)
as being subsidiaries or affiliates of CEA Industries Inc., the &ldquo;Company&rdquo;), hereby confirms its agreement (this &ldquo;Agreement&rdquo;)
with ThinkEquity LLC. (hereinafter referred to as &ldquo;you&rdquo; (including its correlatives) or the &ldquo;Representative&rdquo;),
and with the other underwriters named on <U>Schedule 1</U> hereto for which the Representative is acting as representative (the Representative
and such other underwriters being collectively called the &ldquo;Underwriters&rdquo; or, individually, an &ldquo;Underwriter&rdquo;)
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.
<U>Purchase and Sale of Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.1
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Firm Securities</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.1.1.
<U>Nature and Purchase of Firm Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)
On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company
agrees to issue and sell to the several Underwriters, an aggregate of [&nbsp;&nbsp;] shares (each, a &ldquo;Firm Share&rdquo;, and in
the aggregate, the &ldquo;Firm Shares&rdquo;) of the Company&rsquo;s common stock, par value $0.00001 per share (the &ldquo;Common Stock&rdquo;),
an aggregate of [&nbsp;&nbsp;] pre-funded warrants (each, a &ldquo;Pre-Funded Warrant&rdquo;, and in the aggregate, the &ldquo;Firm Pre-Funded
Warrants&rdquo;) to purchase one share of Common Stock at an exercise price of $0.01 until such time as the Pre-Funded Warrant is exercised
in full, subject to adjustment as provided in the Pre-Funded Warrant, and an aggregate of [&nbsp;&nbsp;] warrants (each, a &ldquo;Warrant&rdquo;,
and in the aggregate, the &ldquo;Firm Warrants&rdquo;; the Firm Shares, Firm Pre-Funded Warrants and the Firm Warrants, the &ldquo;Firm
Securities&rdquo;) to purchase one share of Common Stock at an exercise price of $[&nbsp;&nbsp;] for a period of five (5) years, subject
to adjustment as provided in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(ii)
The Underwriters, severally and not jointly, agree to purchase from the Company the number of Firm Shares, Firm Pre-Funded Warrants and
Firm Warrants set forth opposite their respective names on <U>Schedule 1</U> attached hereto and made a part hereof at a purchase price
of $[&nbsp;&nbsp;] per Firm Share and accompanying Firm Warrant (93% of the per Firm Share offering price, allocated as [&nbsp;&nbsp;]
per Firm Share and $0.00001 per Firm Warrant) and $[&nbsp;&nbsp;] per Firm Pre-Funded Warrant and accompanying Warrant (93% of the per
Firm Share offering price minus $0.01, allocated as [&nbsp;&nbsp;] per Firm Pre-Funded Warrant and $0.00001 per Firm Warrant). The Firm
Securities are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus (as defined
in Section 2.1.1 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.1.2.
<U>Shares Payment and Delivery</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)
Delivery and payment for the Firm Securities shall be made at 10:00 a.m., Eastern time, on the second (2<SUP>nd</SUP>) Business Day following
the effective date (the &ldquo;Effective Date&rdquo;) of the Registration Statement (as defined in Section 2.1.1 below) (or the third
(3<SUP>rd</SUP>) Business Day following the Effective Date if the Registration Statement is declared effective after 4:01 p.m., Eastern
time) or at such earlier time as shall be agreed upon by the Representative and the Company, at the offices of Dentons US LLP, 1221 Avenue
of the Americas, New York, New York 10020 (&ldquo;Representative Counsel&rdquo;), or at such other place (or remotely by facsimile or
other electronic transmission) as shall be agreed upon by the Representative and the Company. The hour and date of delivery and payment
for the Firm Securities is called the &ldquo;Closing Date.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(ii)
Payment for the Firm Securities shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order
of the Company upon delivery of the certificates (in form and substance satisfactory to the Underwriters) representing the Firm Securities
(or through the facilities of the Depository Trust Company (&ldquo;DTC&rdquo;)) for the account of the Underwriters. The Firm Securities
shall be registered in such name or names and in such authorized denominations as the Representative may request in writing prior to
the Closing Date. The Company shall not be obligated to sell or deliver the Firm Securities except upon tender of payment by the Representative
for all of the Firm Securities. The term &ldquo;Business Day&rdquo; means any day other than a Saturday, a Sunday or a legal holiday
or a day on which banking institutions are authorized or obligated by law to close in New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.2
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Over-allotment Option</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.2.1.
<U>Option Shares</U>. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Securities,
the Company hereby grants to the Underwriters an option (the &ldquo;Over-allotment Option&rdquo;) to purchase, in the aggregate, up to
[&nbsp;&nbsp;] additional shares of Common Stock and/or Pre-Funded Warrants, representing 15% of the Firm Shares and Firm Pre-Funded
Warrants sold in the offering from the Company (the &ldquo;Option Shares&rdquo; or &ldquo;Option Pre-Funded Warrants,&rdquo; as applicable)
and/or up to [&nbsp;&nbsp;] additional Warrants to purchase an aggregate of an additional [&nbsp;&nbsp;] shares of Common Stock, representing
15% of the Firm Warrants sold in the offering from the Company (the &ldquo;Option Warrants&rdquo;). The purchase price to be paid per
Option Share or Option Pre-Funded Warrant shall be equal to the price per Firm Share or Firm Pre-Funded Warrant set forth in Section
1.1.1(ii) hereof and the purchase price to be paid per Option Warrant shall be equal to the price per Firm Warrant set forth in Section
1.1.1(ii) hereof. The Over-allotment Option is, at the Underwriters&rsquo; sole discretion, for Option Shares and Option Warrants together,
Option Pre-Funded Warrants and Option Warrants together, solely Option Shares, Solely Option Pre-Funded Warrants, solely Option Warrants,
or any combination thereof (each, an &ldquo;Option Security&rdquo; and collectively, the &ldquo;Option Securities&rdquo;). The Firm Securities
and the Option Securities are collectively referred to as the &ldquo;Securities.&rdquo; The Securities and the Underlying Shares (as
defined below), are collectively referred to as the &ldquo;Public Securities.&rdquo; The Public Securities shall be issued directly by
the Company and shall have the rights and privileges described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus. The Firm Warrants and the Option Warrants, if any, shall be issued pursuant to, and shall have the rights and privileges
set forth in, a warrant agreement, dated on or before the Closing Date, between the Company and Continental Stock Transfer &amp; Trust
Company as warrant agent (the &ldquo;Warrant Agreement&rdquo;). The certificate (the &ldquo;Pre-Funded Warrant Certificate&rdquo;) evidencing
the Firm Pre-Funded Warrants and the Option Pre-Funded Warrants, if any, will be in the form attached hereto as Exhibit A. The offering
and sale of the Public Securities is herein referred to as the &ldquo;Offering.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.2.2.
<U>Exercise of Option</U>. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative
as to all (at any time) or any part (from time to time) of the Option Securities within 45 days after the Effective Date. The Underwriters
shall not be under any obligation to purchase any Option Securities prior to the exercise of the Over-allotment Option. The Over-allotment
Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in
writing by overnight mail, email or facsimile or other electronic transmission setting forth the number of Option Securities to be purchased
and the date and time for delivery of and payment for the Option Securities (the &ldquo;Option Closing Date&rdquo;), which shall not
be later than one (1) full Business Days after the date of the notice or such other time as shall be agreed upon by the Company and the
Representative, at the offices of Representative Counsel or at such other place (including remotely by facsimile, email or other electronic
transmission) as shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Securities does
not occur on the Closing Date, the Option Closing Date will be as set forth in the notice. Upon exercise of the Over-allotment Option
with respect to all or any portion of the Option Securities, subject to the terms and conditions set forth herein, (i) the Company shall
become obligated to sell to the Underwriters the number of Option Securities specified in such notice and (ii) each of the Underwriters,
acting severally and not jointly, shall purchase that portion of the total number of Option Securities then being purchased as set forth
in <U>Schedule 1</U> opposite the name of such Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.2.3.
<U>Payment and Delivery</U>. Payment for the Option Securities shall be made on the Option Closing Date by wire transfer in Federal (same
day) funds, payable to the order of the Company upon delivery to you of certificates (in form and substance satisfactory to the Underwriters)
representing the Option Securities (or through the facilities of DTC) for the account of the Underwriters. The Option Securities shall
be registered in such name or names and in such authorized denominations as the Representative may request in writing prior to the Option
Closing Date. The Company shall not be obligated to sell or deliver the Option Securities except upon tender of payment by the Representative
for applicable Option Securities. An Option Closing Date may be simultaneous with, but not earlier than, the Closing Date; and in the
event that such time and date are simultaneous with the Closing Date, the term &ldquo;Closing Date&rdquo; shall refer to the time and
date of delivery of the Firm Securities and Option Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.3
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Representative&rsquo;s Warrants</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.3.1.
<U>Purchase Warrants</U>. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date,
and the Option Closing Date if applicable, a warrant (&ldquo;Representative&rsquo;s Warrant&rdquo;) for the purchase of an aggregate
of up to [&nbsp;&nbsp;] shares of Common Stock, representing 5% of the Firm Shares, Firm Pre-Funded Warrants, Option Shares and Option
Pre-Funded Warrants sold on such date, for an aggregate purchase price of $100.00. The Representative&rsquo;s Warrant agreement, in the
form attached hereto as <U>Exhibit B</U> (the &ldquo;Representative&rsquo;s Warrant Agreement&rdquo;), shall be exercisable, in whole
or in part, commencing on a date which is one hundred eighty (180) days after the Effective Date and expiring on the five-year anniversary
of the Effective Date at an initial exercise price per share of Common Stock of $[&nbsp;&nbsp;], which is equal to 125% of the initial
public offering price of the Firm Shares. The Representative&rsquo;s Warrant and the shares of Common Stock issuable upon exercise thereof
are hereinafter referred to together as the &ldquo;Representative&rsquo;s Securities.&rdquo; The Representative understands and agrees
that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative&rsquo;s Warrant Agreement
and the underlying shares of Common Stock during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof
shall agree that it will not sell, transfer, assign, pledge or hypothecate the Representative&rsquo;s Warrant Agreement, or any portion
thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic
disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than (i) an
Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representative or of
any such Underwriter or selected dealer, or (iii) as otherwise expressly permitted by FINRA Rule 5110(g); and only if any such transferee
agrees to the foregoing lock-up restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.3.2.
<U>Delivery</U>. Delivery of the Representative&rsquo;s Warrant Agreement shall be made on the Closing Date or Option Closing Date, as
applicable, and shall be issued in the name or names and in such authorized denominations as the Representative may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.
<U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Underwriters as of the Applicable Time
(as defined below), as of the Closing Date and as of the Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.1
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Filing of Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.1.1.
<U>Pursuant to the Securities Act</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
a registration statement, and an amendment or amendments thereto, on Form S-1 (File No. 333-261648), including any related prospectus
or prospectuses, for the registration of the Public Securities and the Representative&rsquo;s Securities under the Securities Act of
1933, as amended (the &ldquo;Securities Act&rdquo;), which registration statement and amendment or amendments have been prepared by the
Company in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission
under the Securities Act (the &ldquo;Securities Act Regulations&rdquo;) and will contain all material statements that are required to
be stated therein in accordance with the Securities Act and the Securities Act Regulations. Except as the context may otherwise require,
such registration statement, as amended, on file with the Commission at the time the registration statement became effective (including
the Preliminary Prospectus (as defined below) included in the registration statement, financial statements, schedules, exhibits and all
other documents filed as a part thereof or incorporated therein by reference and all information deemed to be a part thereof as of the
Effective Date pursuant to paragraph (b) of Rule 430A of the Securities Act Regulations (the &ldquo;Rule 430A Information&rdquo;)), is
referred to herein as the &ldquo;Registration Statement.&rdquo; If the Company files any registration statement pursuant to Rule 462(b)
of the Securities Act Regulations, then after such filing, the term &ldquo;Registration Statement&rdquo; shall include such registration
statement filed pursuant to Rule 462(b). The Registration Statement has been declared effective by the Commission on the date hereof.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Each
prospectus used prior to the effectiveness of the Registration Statement, and each prospectus that omitted the Rule 430A Information
that was used after such effectiveness and prior to the execution and delivery of this Agreement, is herein called a &ldquo;Preliminary
Prospectus.&rdquo; The Preliminary Prospectus, subject to completion, dated [&nbsp;&nbsp;], 2022, that was included in the Registration
Statement immediately prior to the Applicable Time is hereinafter called the &ldquo;Pricing Prospectus.&rdquo; The final prospectus in
the form first furnished to the Underwriters for use in the Offering is hereinafter called the &ldquo;Prospectus.&rdquo; Any reference
to the &ldquo;most recent Preliminary Prospectus&rdquo; shall be deemed to refer to the latest Preliminary Prospectus included in the
Registration Statement. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Applicable
Time&rdquo; means [&nbsp;&nbsp;] [a.m./p.m.], Eastern time, on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Issuer
Free Writing Prospectus&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Securities Act Regulations
(&ldquo;Rule 433&rdquo;), including without limitation any &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the Securities
Act Regulations) relating to the Public Securities that is (i) required to be filed with the Commission by the Company, (ii) a &ldquo;road
show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission,
or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Public Securities
or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission
or, if not required to be filed, in the form retained in the Company&rsquo;s records pursuant to Rule 433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Issuer
General Use Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective
investors (other than a &ldquo;<I>bona fide</I> electronic road show,&rdquo; as defined in Rule 433 (the &ldquo;Bona Fide Electronic
Road Show&rdquo;)), as evidenced by its being specified in <U>Schedule 2-B</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Issuer
Limited Use Free Writing Prospectus&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&ldquo;Pricing
Disclosure Package&rdquo; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Pricing
Prospectus and the information included on <U>Schedule 2-A</U> hereto, all considered together. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.1.2.
<U>Pursuant to the Exchange Act</U>. The Company has filed with the Commission a Form 8-A (File Number 001-[&nbsp;&nbsp;]) providing
for the registration pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
of the shares of Common Stock and the Warrants, which registration statement complies in all material respects with the Exchange Act.
The registration of the shares of Common Stock and the Warrants under the Exchange Act has been declared effective by the Commission
on or prior to the date hereof. The Company has taken no action designed to, or likely to have the effect of, terminating the registration
of the shares of Common Stock and the Warrants under the Exchange Act, nor has the Company received any notification that the Commission
is contemplating terminating such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.2
<U>Stock Exchange Listing</U>. The shares of Common Stock and the Warrants have been approved for listing on the Nasdaq Capital Market
(the &ldquo;Exchange&rdquo;) under the symbol &ldquo;CEAD&rdquo; and &ldquo;CEADW&rdquo;, respectively, and the Company has taken no
action designed to, or likely to have the effect of, delisting the shares of Common Stock and the Warrants from the Exchange, nor has
the Company received any notification that the Exchange is contemplating terminating such listing. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.3
<U>No Stop Orders, etc</U>. Neither the Commission nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued any
order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted
or, to the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied
with each request (if any) from the Commission for additional information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.4
<U>Disclosures in Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.1.
<U>Compliance with Securities Act and 10b-5 Representation</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)
Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material
respects with the requirements of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus, including the prospectus
filed as part of the Registration Statement as originally filed or as part of any amendment or supplement thereto, and the Prospectus,
at the time each was filed with the Commission, complied in all material respects with the requirements of the Securities Act and the
Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in connection with this Offering and the
Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except
to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(ii)
Neither the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date or
at any Option Closing Date (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits or
will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. No post-effective
amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or
in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission. The press releases
disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made and when made, not misleading.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(iii)
The Pricing Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does
not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free Writing Prospectus
hereto does not conflict with the information contained in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus
or the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Pricing Prospectus
as of the Applicable Time, did not include an untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to statements made or statements omitted in reliance upon and in conformity with written
information furnished to the Company with respect to the Underwriters by the Representative expressly for use in the Registration Statement,
the Pricing Prospectus or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such
information provided by or on behalf of any Underwriter consists solely of the following disclosure contained in the &ldquo;Underwriting&rdquo;
section of the Prospectus: the disclosure under the headings &ldquo;Discretionary Accounts,&rdquo; &ldquo;Price Stabilization, Short
Positions and Penalty Bids&rdquo; and &ldquo;Electronic Offer, Sale and Distribution of Securities&rdquo; (the &ldquo;Underwriters&rsquo;
Information&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(iv)
Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time
of any filing with the Commission pursuant to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or will
include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this representation
and warranty shall not apply to the Underwriters&rsquo; Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.2.
<U>Disclosure of Agreements</U>. The agreements and documents described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus conform in all material respects to the descriptions thereof contained therein and there are no agreements or other
documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been
so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by
which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, or (ii) is material to the Company&rsquo;s business, has been duly authorized and validly executed by the Company, is
in full force and effect in all material respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other
parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution provision may
be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms
of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor
may be brought. None of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the Company&rsquo;s
knowledge, any other party is in default thereunder and, to the Company&rsquo;s knowledge, no event has occurred that, with the lapse
of time or the giving of notice, or both, would constitute a default thereunder. To the best of the Company&rsquo;s knowledge, performance
by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable
law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the
Company or any of its assets or businesses (each, a &ldquo;Governmental Entity&rdquo;), including, without limitation, those relating
to environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.3.
<U>Prior Securities Transactions</U>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration
Statement, the Pricing Disclosure Package and the Preliminary Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.4.4.
<U>Regulations</U>. The disclosures in the Registration Statement, the Pricing Disclosure Package and the Prospectus concerning the effects
of federal, state, local and all foreign regulation on the Offering and the Company&rsquo;s business as currently contemplated are correct
in all material respects and no other such regulations are required to be disclosed in the Registration Statement, the Pricing Disclosure
Package and the Prospectus which are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.5
<U>Changes After Dates in Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.5.1.
<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse change
in the financial position or results of operations of the Company, nor any change or development that, singularly or in the aggregate,
would involve a material adverse change or a prospective material adverse change, in or affecting the condition (financial or otherwise),
results of operations, business, assets or prospects of the Company (a &ldquo;Material Adverse Change&rdquo;); (ii) there have been no
material transactions entered into by the Company, other than as contemplated pursuant to this Agreement; (iii) there have been no transactions
entered into by the Company with cultivators of plant-based medicines that sell only to the cannabis industry (a &ldquo;Cannabis-Related
Business&rdquo;) that are not legally licensed in the states in which they operate; and (iv) no officer or director of the Company has
resigned from any position with the Company. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Public Securities contemplated by this Agreement, no event, liability, fact, circumstance,
occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its businesses,
prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable
securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one Trading Day
(as defined below) prior to the date that this representation is made.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.5.2.
<U>Recent Securities Transactions, etc</U>. Subsequent to the respective dates as of which information is given in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has not: (i) issued any securities or incurred
any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution
on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.6
<U>Independent Accountants</U>. To the knowledge of the Company, Sadler, Gibb &amp; Associates LLC (the &ldquo;Auditor&rdquo;), whose
report is filed with the Commission as part of the Registration Statement, the Pricing Disclosure Package and the Prospectus, is an independent
registered public accounting firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting
Oversight Board. The Auditor has not, during the periods covered by the financial statements included in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g)
of the Exchange Act. To the knowledge of the Company, ACM LLP (the &ldquo;Prior Auditor&rdquo;), whose report is filed with the Commission
as part of the Registration Statement, the Pricing Disclosure Package and the Prospectus, is an independent registered public accounting
firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board. The Prior
Auditor has not, during the periods covered by the financial statements included in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.
</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.7
<U>Financial Statements, etc</U>. The financial statements, including the notes thereto and supporting schedules included in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, fairly present the financial position and the results of operations of
the Company at the dates and for the periods to which they apply; and such financial statements have been prepared in conformity with
U.S. generally accepted accounting principles (&ldquo;GAAP&rdquo;), consistently applied throughout the periods involved (provided that
unaudited interim financial statements are subject to year-end audit adjustments that are not expected to be material in the aggregate
and do not contain all footnotes required by GAAP); and the supporting schedules included in the Registration Statement present fairly
the information required to be stated therein. Except as included therein, no historical or pro forma financial statements are required
to be included in the Registration Statement, the Pricing Disclosure Package or the Prospectus under the Securities Act or the Securities
Act Regulations. The pro forma and pro forma as adjusted financial information and the related notes, if any, included in the Registration
Statement, the Pricing Disclosure Package and the Prospectus have been properly compiled and prepared in accordance with the applicable
requirements of the Securities Act and the Securities Act Regulations and present fairly the information shown therein, and the assumptions
used in the preparation thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and
circumstances referred to therein. All disclosures contained in the Registration Statement, the Pricing Disclosure Package or the Prospectus
regarding &ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules and regulations of the Commission), if any,
comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. Each of the
Registration Statement, the Pricing Disclosure Package and the Prospectus discloses all material off-balance sheet transactions, arrangements,
obligations (including contingent obligations), and other relationships of the Company with unconsolidated entities or other persons
that may have a material current or future effect on the Company&rsquo;s financial condition, changes in financial condition, results
of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses. Except as disclosed
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (a) neither the Company nor any of its direct and indirect
subsidiaries, including each entity disclosed or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus
as being a subsidiary of the Company (each, a &ldquo;Subsidiary&rdquo; and, collectively, the &ldquo;Subsidiaries&rdquo;), has incurred
any material liabilities or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course
of business, (b) the Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital
stock, (c) there has not been any change in the capital stock of the Company or any of its Subsidiaries, or, other than in the course
of business, any grants under any stock compensation plan, and (d) there has not been any material adverse change in the Company&rsquo;s
long-term or short-term debt.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.8
<U>Authorized Capital; Options, etc</U>. The Company had, at the date or dates indicated in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions
stated in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company will have on the Closing Date the
adjusted stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Pricing
Disclosure Package and the Prospectus, on the Effective Date, as of the Applicable Time and on the Closing Date and any Option Closing
Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares
of Common Stock of the Company or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts
or commitments to issue or sell shares of Common Stock or any such options, warrants, rights or convertible securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.9
<U>Valid Issuance of Securities, etc.</U></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.9.1.
<U>Outstanding Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by
this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights
of rescission with respect thereto, and are not subject to personal liability by reason of being such holders; and none of such securities
were issued in violation of the preemptive rights of any holders of any security of the Company or similar contractual rights granted
by the Company. The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in
the Registration Statement, the Pricing Disclosure Package and the Prospectus. The offers and sales of the outstanding shares of Common
Stock were at all relevant times either registered under the Securities Act and the applicable state securities or &ldquo;blue sky&rdquo;
laws or, based in part on the representations and warranties of the purchasers of such shares, exempt from such registration requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.9.2.
<U>Securities Sold Pursuant to this Agreement</U>. The Public Securities and Representative&rsquo;s Securities have been duly authorized
for issuance and sale and, when issued and paid for, will be validly issued, fully paid and non-assessable; the holders thereof are not
and will not be subject to personal liability by reason of being such holders. The Public Securities and Representative&rsquo;s Securities
are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights
granted by the Company, and all corporate action required to be taken for the authorization, issuance and sale of the Public Securities
and Representative&rsquo;s Securities has been duly and validly taken. The shares of Common Stock issuable upon exercise of the Pre-Funded
Warrants, the Warrants and the Representative&rsquo;s Warrant (the &ldquo;Underlying Shares&rdquo;) have been duly authorized and reserved
for issuance by all necessary corporate action on the part of the Company and when paid for and issued in accordance with the Pre-Funded
Warrant Certificate, the Warrant Agreement and the Representative&rsquo;s Warrant Agreement, as the case may be, such Underlying Shares
will be validly issued, fully paid and non-assessable and the holders thereof are not and will not be subject to personal liability by
reason of being such holders and such shares of Common Stock are not and will not be subject to the preemptive rights of any holders
of any security of the Company or similar contractual rights granted by the Company. The Public Securities and Representative&rsquo;s
Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement, the Pricing
Disclosure Package and the Prospectus. All corporate action required to be taken for the authorization, issuance and sale of the Pre-Funded
Warrant, the Warrant and the Representative&rsquo;s Warrant Agreement has been duly and validly taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.10
<U>Registration Rights of Third Parties</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities
of the Company have the right to require the Company to register any such securities of the Company under the Securities Act or to include
any such securities in a registration statement to be filed by the Company.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.11
<U>Validity and Binding Effect of Agreements</U>. This Agreement, the Pre-Funded Warrant Certificate, the Warrant Agreement and the Representative&rsquo;s
Warrant Agreement have been duly and validly authorized by the Company, and, when executed and delivered, will constitute, the valid
and binding agreements of the Company, enforceable against the Company in accordance with their respective terms, except: (i) as such
enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally;
(ii) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws; and
(iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses
and to the discretion of the court before which any proceeding therefor may be brought.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.12
<U>No Conflicts, etc</U>. The execution, delivery and performance by the Company of this Agreement, the Pre-Funded Warrant Certificate,
the Warrant Agreement, the Representative&rsquo;s Warrant Agreement and all ancillary documents, the consummation by the Company of the
transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof do not and will not,
with or without the giving of notice or the lapse of time or both: (i) result in a material breach of, or material conflict with, any
of the terms and provisions of, or constitute a material default under, or result in the creation, modification, termination or imposition
of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any agreement or instrument to
which the Company is a party; (ii) result in any violation of the provisions of the Company&rsquo;s Certificate of Incorporation (as
the same have been amended or restated from time to time, the &ldquo;Charter&rdquo;) or the by-laws of the Company (the &ldquo;Bylaws&rdquo;);
or (iii) violate any existing applicable law, rule, regulation, judgment, order or decree of any Governmental Entity as of the date hereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.13
<U>No Defaults; Violations</U>. No material default exists in the due performance and observance of any term, covenant or condition of
any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument
evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party or by which
the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not in violation of any
term or provision of its Charter or Bylaws, or in violation of any franchise, license, permit, applicable law, rule, regulation, judgment
or decree of any Governmental Entity. The Company is not in violation of any applicable federal, state, local and foreign laws (including
common law), rules, regulations, requirements, decisions, judgments, decrees, orders and other legally enforceable requirements regarding
the legality of Cannabis-Related Businesses.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.14
<U>Corporate Power; Licenses; Consents</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.14.1.
<U>Conduct of Business</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the
Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates
and permits of and from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business
purpose as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.14.2.
<U>Transactions Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement, the Pre-Funded
Warrant Certificate, the Warrant Agreement and the Representative&rsquo;s Warrant Agreement and to carry out the provisions and conditions
hereof and thereof, and all consents, authorizations, approvals and orders required in connection therewith have been obtained. No consent,
authorization or order of, and no filing with, any court, government agency or other body is required for the valid issuance, sale and
delivery of the Public Securities and the consummation of the transactions and agreements contemplated by this Agreement, the Pre-Funded
Warrant Certificate, the Warrant Agreement and the Representative&rsquo;s Warrant Agreement and as contemplated by the Registration Statement,
the Pricing Disclosure Package and the Prospectus, except with respect to applicable federal and state securities laws and the rules
and regulations of the Financial Industry Regulatory Authority, Inc. (&ldquo;FINRA&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.15
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires (the &ldquo;Questionnaires&rdquo;)
completed by each of the Company&rsquo;s directors and officers immediately prior to the Offering (the &ldquo;Insiders&rdquo;) as supplemented
by all information concerning the Company&rsquo;s directors, officers and principal shareholders as described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, as well as in the Lock-Up Agreement (as defined in Section 2.24 below), provided to
the Underwriters, is true and correct in all material respects and the Company has not become aware of any information which would cause
the information disclosed in the Questionnaires to become materially inaccurate and incorrect.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.16
<U>Litigation; Governmental Proceedings</U>. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or
governmental proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company or, to the Company&rsquo;s
knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the Pricing Disclosure Package
and the Prospectus or in connection with the Company&rsquo;s listing application for the listing of the Public Securities on the Exchange,
or which adversely affects or challenges the legality, validity or enforceability of this Agreement, the Pre-Funded Warrant Certificates,
the Warrant Agreement, the Representative&rsquo;s Warrant Agreement or the Public Securities. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.17
<U>Good Standing</U>. The Company has been duly organized and is validly existing as a corporation and is in good standing under the
laws of the State of Nevada as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction
in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify,
singularly or in the aggregate, would not have or reasonably be expected to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.18
<U>Insurance</U>. The Company carries or is entitled to the benefits of insurance, with reputable insurers, in such amounts and covering
such risks which the Company believes are adequate, including, but not limited to, directors and officers insurance coverage at least
equal to $3,000,000 and all such insurance is in full force and effect. The Company has no reason to believe that it will not be able
(i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions
as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse
Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.19
<U>Transactions Affecting Disclosure to FINRA</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.1.
<U>Finder&rsquo;s Fees</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there
are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder&rsquo;s, consulting or origination
fee by the Company or any Insider with respect to the sale of the Public Securities hereunder or any other arrangements, agreements or
understandings of the Company or, to the Company&rsquo;s knowledge, any of its shareholders that may affect the Underwriters&rsquo; compensation,
as determined by FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.2.
<U>Payments Within Twelve (12) Months</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s
fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons
who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation
or association with any FINRA member, within the twelve (12) months prior to the Effective Date, other than the payment to the Underwriters
as provided hereunder in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.3.
<U>Use of Proceeds</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its
affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.4.
<U>FINRA Affiliation</U>. There is no (i) officer or director of the Company, (ii) to the Company&rsquo;s knowledge, beneficial owner
of 5% or more of any class of the Company&rsquo;s securities or (iii) to the Company&rsquo;s knowledge, beneficial owner of the Company&rsquo;s
unregistered equity securities which were acquired during the 180-day period immediately preceding the filing of the Registration Statement
that is an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules
and regulations of FINRA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.19.5.
<U>Information</U>. All information provided by the Company in its FINRA questionnaire to Representative Counsel specifically for use
by Representative Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct
and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.20
<U>Foreign Corrupt Practices Act</U>. None of the Company and its Subsidiaries or, to the Company&rsquo;s knowledge, any director, officer,
agent, employee or affiliate of the Company and its Subsidiaries or any other person acting on behalf of the Company and its Subsidiaries,
has, directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers
in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of
any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic
or foreign) or other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection
with any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil, criminal or governmental
litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in the future,
might adversely affect the assets, business, operations or prospects of the Company. The Company has taken reasonable steps to ensure
that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the Foreign Corrupt
Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.21
<U>Compliance with OFAC</U>. None of the Company and its Subsidiaries or, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company and its Subsidiaries or any other person acting on behalf of the Company and its Subsidiaries, is
currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;OFAC&rdquo;),
and the Company will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any
person currently subject to any U.S. sanctions administered by OFAC.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.22
<U>Money Laundering Laws</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &ldquo;Money Laundering
Laws&rdquo;); and no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the Money
Laundering Laws is pending or, to the best knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.23
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to you or to Representative
Counsel shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.24
<U>Lock-Up Agreements. Schedule 3</U> hereto contains a complete and accurate list of the Company&rsquo;s officers, directors and each
owner of at least 5% of the Company&rsquo;s outstanding shares of Common Stock (or securities convertible or exercisable into shares
of Common Stock) (collectively, the &ldquo;Lock-Up Parties&rdquo;). The Company has caused each of the Lock-Up Parties to deliver to
the Representative an executed Lock-Up Agreement, in the form attached hereto as <U>Exhibit C</U> (the &ldquo;Lock-Up Agreement&rdquo;)
prior to the execution of this Agreement. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.25
<U>Subsidiaries</U>. All direct and indirect Subsidiaries of the Company are duly organized and in good standing under the laws of the
place of organization or incorporation, and each Subsidiary is in good standing in each jurisdiction in which its ownership or lease
of property or the conduct of business requires such qualification, except where the failure to qualify would not have a material adverse
effect on the assets, business or operations of the Company taken as a whole. The Company&rsquo;s ownership and control of each Subsidiary
is as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.26
<U>Related Party Transactions</U>. There are no business relationships or related party transactions involving the Company or any other
person required to be described in the Registration Statement, the Pricing Disclosure Package and the Prospectus that have not been described
as required.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.27
<U>Board of Directors</U>. The Board of Directors of the Company is comprised of the persons set forth under the heading of the Pricing
Prospectus and the Prospectus captioned &ldquo;Management.&rdquo; The qualifications of the persons serving as board members and the
overall composition of the board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules
promulgated thereunder (the &ldquo;Sarbanes-Oxley Act&rdquo;) applicable to the Company and the listing rules of the Exchange. At least
one member of the Audit Committee of the Board of Directors of the Company qualifies as an &ldquo;audit committee financial expert,&rdquo;
as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition, at least a majority of the persons serving
on the Board of Directors qualify as &ldquo;independent,&rdquo; as defined under the listing rules of the Exchange.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.28
<U>Sarbanes-Oxley Compliance</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.28.1.
<U>Disclosure Controls</U>. The Company has developed and currently maintains disclosure controls and procedures that will comply with
Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that all material
information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company&rsquo;s
Exchange Act filings and other public disclosure documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.28.2.
<U>Compliance</U>. The Company is, or at the Applicable Time and on the Closing Date will be, in material compliance with the provisions
of the Sarbanes-Oxley Act applicable to it, as a Smaller Reporting Company, and has implemented or will implement such programs and has
taken reasonable steps to ensure the Company&rsquo;s future compliance (not later than the relevant statutory and regulatory deadlines
therefor) with all of the material provisions of the Sarbanes-Oxley Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.29
<U>Accounting Controls</U>. The Company and its Subsidiaries maintain systems of &ldquo;internal control over financial reporting&rdquo;
(as defined under Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and
have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons
performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. Except as disclosed in the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and
the Quarterly Reports on Form 10-Q filed during fiscal year 2021, the Company is not aware of any material weaknesses in its internal
controls. The Company&rsquo;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all
significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are known
to the Company&rsquo;s management and that have adversely affected or are reasonably likely to adversely affect the Company&rsquo;s ability
to record, process, summarize and report financial information; and (ii) any fraud known to the Company&rsquo;s management, whether or
not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal controls over financial
reporting.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.30
<U>No Investment Company Status</U>. The Company is not and, after giving effect to the Offering and the application of the proceeds
thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be, required to register
as an &ldquo;investment company,&rdquo; as defined in the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.31
<U>No Labor Disputes</U>. No labor dispute with the employees of the Company or any of its Subsidiaries exists or, to the knowledge of
the Company, is imminent. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.32
<U>Intellectual Property Rights</U>. The Company and each of its Subsidiaries owns or possesses or has valid rights to use all patents,
patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses,
inventions, trade secrets and similar rights (&ldquo;Intellectual Property Rights&rdquo;) necessary for the conduct of the business of
the Company and its Subsidiaries as currently carried on and as described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus. To the knowledge of the Company, no action or use by the Company or any of its Subsidiaries necessary for the conduct
of its business as currently carried on and as described in the Registration Statement and the Prospectus will involve or give rise to
any infringement of, or license or similar fees for, any Intellectual Property Rights of others. Neither the Company nor any of its Subsidiaries
has received any notice alleging any such infringement, fee or conflict with asserted Intellectual Property Rights of others. To the
knowledge of the Company, there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property
Rights owned by the Company. There is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by
others challenging the rights of the Company in or to any such Intellectual Property Rights, and the Company is unaware of any facts
which would form a reasonable basis for any such claim, that would, individually or in the aggregate, together with any other claims
in this Section 2.32, reasonably be expected to result in a Material Adverse Change. The Intellectual Property Rights owned by the Company
and, to the knowledge of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged by a court of competent
jurisdiction invalid or unenforceable, in whole or in part, and there is no pending or, to the Company&rsquo;s knowledge, threatened
action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and the Company
is unaware of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together
with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change. There is no pending or, to
the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others that the Company infringes, misappropriates or
otherwise violates any Intellectual Property Rights or other proprietary rights of others, the Company has not received any written notice
of such claim and the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually
or in the aggregate, together with any other claims in this Section 2.32, reasonably be expected to result in a Material Adverse Change.
To the Company&rsquo;s knowledge, no employee of the Company is in or has ever been in violation in any material respect of any term
of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation
agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates
to such employee&rsquo;s employment with the Company, or actions undertaken by the employee while employed with the Company and could
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s knowledge, all
material technical information developed by and belonging to the Company which has not been patented has been kept confidential. The
Company is not a party to or bound by any options, licenses or agreements with respect to the Intellectual Property Rights of any other
person or entity that are required to be set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus and
are not described therein. The Registration Statement, the Pricing Disclosure Package and the Prospectus contain in all material respects
the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company has been obtained
or is being used by the Company in violation of any contractual obligation binding on the Company or, to the Company&rsquo;s knowledge,
any of its officers, directors or employees, or otherwise in violation of the rights of any persons. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.33
<U>Taxes</U>. Each of the Company and its Subsidiaries has filed all returns (as hereinafter defined) required to be filed with taxing
authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof. Each of the Company and its Subsidiaries
has paid all taxes (as hereinafter defined) shown as due on such returns that were filed and has paid all taxes imposed on or assessed
against the Company or such respective Subsidiary. The provisions for taxes payable, if any, shown on the financial statements filed
with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods
to and including the dates of such consolidated financial statements. Except as disclosed in writing to the Underwriters, (i) no issues
have been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as due from
the Company or its Subsidiaries, and (ii) no waivers of statutes of limitation with respect to the returns or collection of taxes have
been given by or requested from the Company or its Subsidiaries. The term &ldquo;taxes&rdquo; means all federal, state, local, foreign
and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service
use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or
other taxes, fees, assessments or charges of any kind whatsoever, together with any interest and any penalties, additions to tax or additional
amounts with respect thereto. The term &ldquo;returns&rdquo; means all returns, declarations, reports, statements and other documents
required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.34
<U>ERISA Compliance</U>. The Company and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement Income Security
Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;ERISA&rdquo;)) established
or maintained by the Company or its &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all material respects with
ERISA. &ldquo;ERISA Affiliate&rdquo; means, with respect to the Company, any member of any group of organizations described in Sections
414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder
(the &ldquo;Code&rdquo;) of which the Company is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or
is reasonably expected to occur with respect to any &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any
of its ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any of its ERISA Affiliates,
if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo; (as
defined under ERISA). Neither the Company nor any of its ERISA Affiliates has incurred or reasonably expects to incur any material liability
under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee benefit plan&rdquo; or (ii) Sections
412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any of its
ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge of the Company,
nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.35
<U>Compliance with Laws</U>. The Company: (A) is and at all times has been in compliance with all statutes, rules, or regulations applicable
to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale,
offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company, including but not limited
to those related to Cannabis-Related Businesses (&ldquo;Applicable Laws&rdquo;), except as could not (except to those related to Cannabis-Related
Businesses), individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (B) has not received any warning
letter, untitled letter or other correspondence or notice from any other governmental authority alleging or asserting noncompliance with
any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto
required by any such Applicable Laws (&ldquo;Authorizations&rdquo;); (C) possesses all material Authorizations and such Authorizations
are valid and in full force and effect and are not in material violation of any term of any such Authorizations; (D) has not received
notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any governmental
authority or third party alleging that any product operation or activity conducted by the Company is in violation of any Applicable Laws
or Authorizations and has no knowledge that any such governmental authority or third party is considering any such claim, litigation,
arbitration, action, suit, investigation or proceeding; (E) has not received notice that any governmental authority has taken, is taking
or intends to take action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental authority
is considering such action; and (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports,
documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the
date filed (or were corrected or supplemented by a subsequent submission).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.36
<U>Ineligible Issuer</U>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness
of the Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant
made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Public Securities and at the date
hereof, the Company was and is an &ldquo;ineligible issuer,&rdquo; as defined in Rule 405.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.37
<U>Real Property</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company
and its Subsidiaries have good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real
or personal property which are material to the business of the Company and its Subsidiaries taken as a whole, in each case free and clear
of all liens, encumbrances, security interests, claims and defects that do not, singly or in the aggregate, materially affect the value
of such property and do not interfere with the use made and proposed to be made of such property by the Company or its Subsidiaries;
and all of the leases and subleases material to the business of the Company and its subsidiaries, considered as one enterprise, and under
which the Company or any of its Subsidiaries holds properties described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, are in full force and effect, and neither the Company nor any Subsidiary has received any notice of any material
claim of any sort that has been asserted by anyone adverse to the rights of the Company or any Subsidiary under any of the leases or
subleases mentioned above, or affecting or questioning the rights of the Company or such Subsidiary to the continued possession of the
leased or subleased premises under any such lease or sublease.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.38
<U>Contracts Affecting Capital</U>. There are no transactions, arrangements or other relationships between and/or among the Company,
any of its affiliates (as such term is defined in Rule 405 of the Securities Act Regulations) and any unconsolidated entity, including,
but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially
affect the Company&rsquo;s or its Subsidiaries&rsquo; liquidity or the availability of or requirements for their capital resources required
to be described or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus which have
not been described or incorporated by reference as required.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.39
<U>Loans to Directors or Officers</U>. There are no outstanding loans, advances (except normal advances for business expenses in the
ordinary course of business) or guarantees or indebtedness by the Company or its Subsidiaries to or for the benefit of any of the officers
or directors of the Company or its Subsidiaries or any of their respective family members, except as disclosed in the Registration Statement,
the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.40
<U>Smaller Reporting Company</U>. As of the time of filing of the Registration Statement, the Company was a &ldquo;smaller reporting
company,&rdquo; as defined in Rule 12b-2 of the Exchange Act Regulations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.41
<U>Industry Data</U>. The statistical and market-related data included in each of the Registration Statement, the Pricing Disclosure
Package and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and
accurate or represent the Company&rsquo;s good faith estimates that are made on the basis of data derived from such sources.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.42
<U>Reverse Stock Split</U>. The Company has taken all necessary corporate action and filed a certificate of amendment to the certificate
of incorporation of the Company to effectuate a reverse stock split of its shares of Common Stock on the basis of one (1) such share
for each one hundred and fifty (150) issued and outstanding shares thereof (the &ldquo;Reverse Stock Split&rdquo;).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.43
<U>[Reserved]</U>. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.44
<U>Testing-the-Waters Communications</U>. The Company has not (i) alone engaged in any Testing-the-Waters Communications, other than
Testing-the-Waters Communications with the written consent of the Representative and with entities that are qualified institutional buyers
within the meaning of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule 501
under the Securities Act and (ii) authorized anyone other than the Representative to engage in Testing-the-Waters Communications. The
Company confirms that the Representative has been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The
Company has not distributed any Written Testing-the-Waters Communications other than those listed on <U>Schedule 2-C</U> hereto. &ldquo;Testing-the-Waters
Communication&rdquo; means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities
Act. &ldquo;Written Testing-the-Waters Communication&rdquo; means any Testing-the-Waters Communication that is a written communication
within the meaning of Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.45
<U>Electronic Road Show</U>. The Company has made available a Bona Fide Electronic Road Show in compliance with Rule 433(d)(8)(ii) of
the Securities Act Regulations such that no filing of any &ldquo;road show&rdquo; (as defined in Rule 433(h) of the Securities Act Regulations)
is required in connection with the Offering.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.46
<U>Margin Securities</U>. The Company owns no &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of
Governors of the Federal Reserve System (the &ldquo;Federal Reserve Board&rdquo;), and none of the proceeds of Offering will be used,
directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness
which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of
Common Stock to be considered a &ldquo;purpose credit&rdquo; within the meanings of Regulation T, U or X of the Federal Reserve Board.
</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.47
<U>Compliance with Cannabis Laws</U>. To the best knowledge of the Company, the Company and its Subsidiaries are in compliance with all,
and have not violated any, applicable federal, state, local and foreign laws (including common law), rules, regulations, requirements,
decisions, judgments, decrees, orders and other legally enforceable requirements regarding the legality of Cannabis-Related Businesses.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.48
<U>Environmental Laws</U>. The Company and the Subsidiaries are in compliance with any and all applicable federal, state, local, and
foreign laws, rules, regulations, requirements, decisions and orders relating to the protection of human health and safety, the environment,
or hazardous or toxic substances, wastes, pollutants, or contaminants (collectively the &ldquo;Environmental Laws&rdquo;), have received
and are in compliance with all permits, licenses, certificates or other authorizations or approvals required of them under applicable
Environmental Laws to conduct their respective businesses, and have not received notice of any actual or potential liability for the
investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants, or contaminants, and
there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.
<U>Covenants of the Company</U>. The Company covenants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.1
<U>Amendments to Registration Statement</U>. The Company shall deliver to the Representative, prior to filing, any amendment or supplement
to the Registration Statement or Prospectus proposed to be filed after the Effective Date and not file any such amendment or supplement
to which the Representative shall reasonably object in writing. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.2
<U>Federal Securities Laws</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.1.
<U>Compliance</U>. The Company, subject to Section 3.2.2, shall comply with the requirements of Rule 430A of the Securities Act Regulations,
and will notify the Representative promptly, and confirm the notice in writing, (i) when any post-effective amendment to the Registration
Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed; (ii) of the receipt of any comments
from the Commission; (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement
to the Prospectus or for additional information; (iv) of the issuance by the Commission of any stop order suspending the effectiveness
of the Registration Statement or any post-effective amendment or of any order preventing or suspending the use of any Preliminary Prospectus
or the Prospectus, or of the suspension of the qualification of the Public Securities and Representative&rsquo;s Securities for offering
or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes or of any examination pursuant
to Section 8(d) or 8(e) of the Securities Act concerning the Registration Statement and (v) if the Company becomes the subject of a proceeding
under Section 8A of the Securities Act in connection with the Offering of the Public Securities and Representative&rsquo;s Securities.
The Company shall effect all filings required under Rule 424(b) of the Securities Act Regulations, in the manner and within the time
period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and shall take such steps as it deems necessary to ascertain promptly
whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that
it was not, it will promptly file such prospectus. The Company shall use its best efforts to prevent the issuance of any stop order,
prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.2.
<U>Continued Compliance</U>. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the
Exchange Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement,
the Pre-Funded Warrant Certificates, the Warrant Agreement and in the Registration Statement, the Pricing Disclosure Package and the
Prospectus. If at any time when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule 172 of
the Securities Act Regulations (&ldquo;Rule 172&rdquo;), would be) required by the Securities Act to be delivered in connection with
sales of the Public Securities, any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of
Representative Counsel or counsel for the Company, to (i) amend the Registration Statement in order that the Registration Statement will
not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make
the statements therein not misleading; (ii) amend or supplement the Pricing Disclosure Package or the Prospectus in order that the Pricing
Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time
it is delivered to a purchaser or (iii) amend the Registration Statement or amend or supplement the Pricing Disclosure Package or the
Prospectus, as the case may be, in order to comply with the requirements of the Securities Act or the Securities Act Regulations, the
Company will promptly (A) give the Representative notice of such event; (B) prepare any amendment or supplement as may be necessary to
correct such statement or omission or to make the Registration Statement, the Pricing Disclosure Package or the Prospectus comply with
such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish the Representative with copies of any
such amendment or supplement and (C) file with the Commission any such amendment or supplement; provided that the Company shall not file
or use any such amendment or supplement to which the Representative or Representative Counsel shall reasonably object. The Company will
furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters may reasonably request. The Company
has given the Representative notice of any filings made pursuant to the Exchange Act or the Exchange Act Regulations within 48 hours
prior to the Applicable Time. The Company shall give the Representative notice of its intention to make any such filing from the Applicable
Time until the later of the Closing Date and the exercise in full or expiration of the Over-allotment Option specified in Section 1.2
hereof and will furnish the Representative with copies of the related document(s) a reasonable amount of time prior to such proposed
filing, as the case may be, and will not file or use any such document to which the Representative or Representative Counsel shall reasonably
object. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.3.
<U>Exchange Act Registration</U>. Until the later of (i) three (3) years after the date of this Agreement and (ii) the expiration date
of the Pre-Funded Warrants and Warrants (or the date that all of the Pre-Funded Warrants and Warrants have been exercised, if earlier),
the Company shall use its reasonable best efforts to maintain the registration of the shares of Common Stock and the Warrants under the
Exchange Act. The Company shall not deregister the shares of Common Stock and the Warrants under the Exchange Act without the prior written
consent of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.4.
<U>Free Writing Prospectuses</U>. The Company agrees that, unless it obtains the prior written consent of the Representative, it shall
not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a &ldquo;free writing prospectus,&rdquo; or a portion thereof, required to be filed by the Company with the Commission or
retained by the Company under Rule 433; provided that the Representative shall be deemed to have consented to each Issuer General Use
Free Writing Prospectus <U>set forth on Schedule 2-B</U> hereto and any &ldquo;road show that is a written communication&rdquo; within
the meaning of Rule 433(d)(8)(i) that has been reviewed by the Representative. The Company represents that it has treated or agrees that
it will treat each such free writing prospectus consented to, or deemed consented to, by the Underwriters as an &ldquo;issuer free writing
prospectus,&rdquo; as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with
respect thereto, including timely filing with the Commission where required, legending and record keeping. If at any time following issuance
of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus
conflicted or would conflict with the information contained in the Registration Statement or included or would include an untrue statement
of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light
of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Underwriters and will promptly
amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement
or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.2.5.
<U>Testing-the-Waters Communications</U>. If at any time following the distribution of any Written Testing-the-Waters Communication there
occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include
an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances existing at that subsequent time, not misleading, the Company shall promptly notify the Representative
and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such
untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.3
<U>Delivery to the Underwriters of Registration Statements</U>. The Company upon request shall deliver to the Representative and Representative
Counsel, without charge, signed copies of the Registration Statement as originally filed and each amendment thereto (including exhibits
filed therewith) and signed copies of all consents and certificates of experts, and will also deliver to the Underwriters, without charge,
a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) for each of the Underwriters,
provided if such conformed copies are available on EDGAR, such delivery requirement is satisfied. The copies of the Registration Statement
and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with
the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.4
<U>Delivery to the Underwriters of Prospectuses</U>. The Company has delivered or made available or will deliver or make available to
each Underwriter, without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and the Company
hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter,
without charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule
172, would be) required to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or supplemented)
as such Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will
be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted
by Regulation S-T.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.5
<U>Effectiveness and Events Requiring Notice to the Representative</U>. The Company shall use its reasonable best efforts to cause the
Registration Statement to remain effective with a current prospectus through and including the expiration date of the Pre-Funded Warrants
and Warrants (or the date that all of the Pre-Funded Warrants and Warrants have been exercised, if earlier), and shall notify the Representative
immediately and confirm the notice in writing: (i) of the effectiveness of the Registration Statement and any amendment thereto; (ii)
of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that purpose; (iii)
of the issuance by any state securities commission of any proceedings for the suspension of the qualification of the Public Securities
for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv) of the mailing
and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus; (v) of the receipt
of any comments or request for any additional information from the Commission; and (vi) of the happening of any event during the period
described in this Section 3.5 that, in the judgment of the Company, makes any statement of a material fact made in the Registration Statement,
the Pricing Disclosure Package or the Prospectus untrue or that requires the making of any changes in (a) the Registration Statement
in order to make the statements therein not misleading, or (b) in the Pricing Disclosure Package or the Prospectus in order to make the
statements therein, in light of the circumstances under which they were made, not misleading. If the Commission or any state securities
commission shall enter a stop order or suspend such qualification at any time, the Company shall make every reasonable effort to obtain
promptly the lifting of such order.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.6
<U>Review of Financial Statements.</U> For a period of five (5) years after the date of this Agreement, the Company, at its expense,
shall cause its regularly engaged independent registered public accounting firm to review (but not audit) the Company&rsquo;s financial
statements for each of the three fiscal quarters immediately preceding the announcement of any quarterly financial information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.7
<U>Listing</U>. The Company shall use its reasonable best efforts to maintain the listing of the shares of Common Stock and the Warrants
(including the Public Securities) on the Exchange until the later of (i) three (3) years after the date of this Agreement and (ii) the
expiration date of the Pre-Funded Warrants and Warrants (or the date that all of the Pre-Funded Warrants and Warrants have been exercised,
if earlier).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.8
<U>Financial Public Relations Firm</U>. Within 60 calendar days after the Effective Date, the Company shall have retained a financial
public relations firm reasonably acceptable to the Representative and the Company, which firm shall be experienced in assisting issuers
in initial public offerings of securities and in their relations with their security holders, and shall retain such firm or another firm
reasonably acceptable to the Representative for a period of not less than two (2) years after the Effective Date.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.9
<U>Reports to the Representative</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.9.1.
<U>Periodic Reports, etc</U>. For a period of three (3) years after the date of this Agreement, the Company shall furnish or make available
to the Representative copies of such financial statements and other periodic and special reports as the Company from time to time furnishes
generally to holders of any class of its securities and also promptly furnish to the Representative: (i) a copy of each periodic report
the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations; (ii) a copy of every
press release and every news item and article with respect to the Company or its affairs which was released by the Company; (iii) a copy
of each Form 8-K prepared and filed by the Company; (iv) a copy of each registration statement filed by the Company under the Securities
Act; and (v) such additional documents and information with respect to the Company and the affairs of any future subsidiaries of the
Company as the Representative may from time to time reasonably request; provided the Representative shall sign, if requested by the Company,
a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative and Representative Counsel in
connection with the Representative&rsquo;s receipt of such information. Documents filed with the Commission pursuant to its EDGAR system
and with respect to item (ii), disseminated widely to the public, shall be deemed to have been delivered to the Representative pursuant
to this Section 3.9.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.9.2.
<U>Transfer Agent; Transfer Sheets</U>. Until the later of (i) three (3) years after the date of this Agreement and (ii) the expiration
date of the Pre-Funded Warrants and Warrants (or the date that all of the Pre-Funded Warrants and Warrants have been exercised, if earlier),
the Company shall retain a transfer agent and registrar acceptable to the Representative (the &ldquo;Transfer Agent&rdquo;) and shall
furnish to the Representative at the Company&rsquo;s sole cost and expense such transfer sheets of the Company&rsquo;s securities as
the Representative may reasonably request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and DTC.
Continental Stock Transfer &amp; Trust Company is acceptable to the Representative to act as Transfer Agent for the shares of Common
Stock and the Warrants. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.9.3.
<U>Trading Reports</U>. During such time as the Public Securities are listed on the Exchange, the Company shall provide to the Representative,
at the Company&rsquo;s expense, such reports published by the Exchange relating to price trading of the Public Securities, as the Representative
shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.10
<U>Payment of Expenses</U></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.10.1.
<U>General Expenses Related to the Offering</U>. The Company hereby agrees to pay on each of the Closing Date and the Option Closing
Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company
under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the
Public Securities to be sold in the Offering (including the Option Securities) with the Commission; (b) all Public Offering Filing System
filing fees associated with the review of the Offering by FINRA; (c) all fees and expenses relating to the listing of such Public Securities
on the Exchange and such other stock exchanges as the Company and the Representative together determine; (d) all fees, expenses and disbursements
relating to background checks of the Company&rsquo;s officers and directors in an amount not to exceed $15,000 in the aggregate; (e)
all fees, expenses and disbursements relating to the registration or qualification of the Public Securities under the &ldquo;blue sky&rdquo;
securities laws of such states and other jurisdictions as the Representative may reasonably designate (including, without limitation,
all filing and registration fees); (f) all fees, expenses and disbursements relating to the registration, qualification or exemption
of the Public Securities under the securities laws of such foreign jurisdictions as the Representative may reasonably designate; (g)
the costs of all mailing and printing of the underwriting documents (including, without limitation, the Underwriting Agreement, any Blue
Sky Surveys and, if appropriate, any Agreement Among Underwriters, Selected Dealers&rsquo; Agreement, Underwriters&rsquo; Questionnaire
and Power of Attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary
and final Prospectuses as the Representative may reasonably deem necessary; (h) the costs and expenses of a public relations firm; (i)
the costs of preparing, printing and delivering certificates representing the Public Securities; (j) fees and expenses of the transfer
agent for the Public Securities; (k) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company
to the Underwriters; (l) the fees and expenses of the Company&rsquo;s accountants; (m) the fees and expenses of the Company&rsquo;s legal
counsel and other agents and representatives; (n) fees and expenses of Representative Counsel not to exceed $125,000; and (o) the $29,500
cost associated with the Underwriters&rsquo; use of Ipreo&rsquo;s book-building, prospectus tracking and compliance software for the
Offering. The Representative may deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or the Option
Closing Date, if any, the expenses set forth herein to be paid by the Company to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.10.2.
<U>Non-accountable Expenses</U>. The Company further agrees that, in addition to the expenses payable pursuant to Section 3.10.1, on
the Closing Date it shall pay to the Representative, by deduction from the net proceeds of the Offering contemplated herein, a non-accountable
expense allowance equal to one percent (1%) of the gross proceeds received by the Company from the sale of the Firm Securities (presuming
exercise of any Pre-Funded Warrants issued; excluding the Option Securities), provided, however, that in the event that the Offering
is terminated, the Company agrees to reimburse the Underwriters pursuant to Section 8.3 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.11
<U>Application of Net Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent
with the application thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure
Package and the Prospectus.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.12
<U>Delivery of Earnings Statements to Security Holders</U>. The Company shall make generally available to its security holders as soon
as practicable, but not later than the first day of the fifteenth (15<SUP>th</SUP>) full calendar month following the date of this Agreement,
an earnings statement (which need not be certified by an independent registered public accounting firm unless required by the Securities
Act or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act)
covering a period of at least twelve (12) consecutive months beginning after the date of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.13
<U>Stabilization</U>. Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent
of the Representative) has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might
reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.14
<U>Internal Controls</U>. The Company shall maintain a system of internal accounting controls sufficient to provide reasonable assurances
that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorization; (ii) transactions are recorded
as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets;
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the recorded
accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.15
<U>Accountants</U>. As of the date of this Agreement, the Company shall retain an independent registered public accounting firm reasonably
acceptable to the Representative, and the Company shall continue to retain a nationally recognized independent registered public accounting
firm for a period of at least three (3) years after the date of this Agreement. The Representative acknowledges that the Auditor is acceptable
to the Representative.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.16
<U>FINRA</U>. For a period of 90 days from the later of the Closing Date or the Option Closing Date, the Company shall advise the Representative
(who shall make an appropriate filing with FINRA) if it is or becomes aware that (i) any officer or director of the Company, (ii) any
beneficial owner of 5% or more of any class of the Company&rsquo;s securities or (iii) any beneficial owner of the Company&rsquo;s unregistered
equity securities which were acquired during the 180 days immediately preceding the filing of the Registration Statement is or becomes
an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations
of FINRA).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.17
<U>No Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely
contractual in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in a fiduciary
capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other
transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.18
<U>Company Lock-Up Agreements</U>. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.18.1.
<U>Restriction on Sales of Securities</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior
written consent of the Representative, it will not, for a period of 90 days after the date of this Agreement (the &ldquo;Lock-Up Period&rdquo;),
(i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock
of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file
or cause to be filed any registration statement with the Commission relating to the offering of any shares of capital stock of the Company
or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company (other than a registration
statement on Form S-8); (iii) complete any offering of debt securities of the Company, other than entering into a line of credit with
a traditional bank or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of capital stock of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv)
above is to be settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
restrictions contained in this Section 3.18.1 shall not apply to (i) the Public Securities and the Representative&rsquo;s Securities
to be sold hereunder, (ii) the issuance by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the
conversion of a security outstanding on the date hereof, which is disclosed in the Registration Statement, Pricing Disclosure Package
and Prospectus, provided that such options, warrants, and securities have not been amended since the date of this Agreement to increase
the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the
term of such securities, or (iii) the issuance by the Company of stock options or shares of capital stock of the Company under any equity
compensation plan of the Company, provided that in each of (ii) and (iii) above, the underlying shares shall be restricted from sale
during the entire Lock-Up Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.18.2.
<U>Restriction on Continuous Offerings</U>. Notwithstanding the restrictions contained in Section 3.18.1, the Company, on behalf of itself
and any successor entity, agrees that, without the prior written consent of the Representative, it will not, for a period of 12 months
after the date of this Agreement, directly or indirectly in any &ldquo;at-the-market&rdquo; or continuous equity transaction, offer to
sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of capital stock of the Company or any securities
convertible into or exercisable or exchangeable for shares of capital stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.19
<U>Release of D&amp;O Lock-up Period</U>. If the Representative, in its sole discretion, agrees to release or waive the restrictions
set forth in the Lock-Up Agreements described in Section 2.24 hereof for an officer or director of the Company and provides the Company
with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver, the
Company agrees to announce the impending release or waiver by a press release substantially in the form of <U>Exhibit D</U> hereto through
a major news service at least two (2) Business Days before the effective date of the release or waiver.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.20
<U>Blue Sky Qualifications</U>. The Company shall use its reasonable best efforts, in cooperation with the Underwriters, if necessary,
to qualify the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic
or foreign) as the Representative may designate and to maintain such qualifications in effect so long as required to complete the distribution
of the Public Securities; provided, however, that the Company shall not be obligated to file any general consent to service of process
or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject
itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.21
<U>Reporting Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the
exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required to be filed
with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations. Additionally,
the Company shall report the use of proceeds from the issuance of the Public Securities as may be required under Rule 463 under the Securities
Act Regulations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.22
<U>[Reserved]</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.
<U>Conditions of Underwriters&rsquo; Obligations</U>. The obligations of the Underwriters to purchase and pay for the Public Securities,
as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date
hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the
Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.1
<U>Regulatory Matters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.1.1.
<U>Effectiveness of Registration Statement; Rule 430A Information</U>. The Registration Statement has become effective not later than
5:00 p.m., Eastern time, on the date of this Agreement or such later date and time as shall be consented to in writing by you, and, at
each of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of the Registration Statement or any
post-effective amendment thereto has been issued under the Securities Act, no order preventing or suspending the use of any Preliminary
Prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to
the Company&rsquo;s knowledge, contemplated by the Commission. The Company has complied with each request (if any) from the Commission
for additional information. The Prospectus containing the Rule 430A Information shall have been filed with the Commission in the manner
and within the time frame required by Rule 424(b) (without reliance on Rule 424(b)(8)) or a post-effective amendment providing such information
shall have been filed with, and declared effective by, the Commission in accordance with the requirements of Rule 430A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.1.2.
<U>FINRA Clearance</U>. On or before the date of this Agreement, the Representative shall have received clearance from FINRA as to the
amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.1.3.
<U>Exchange Stock Market Clearance</U>. On the Closing Date, the Company&rsquo;s shares of Common Stock, including the Firm Shares and
the Underlying Shares, and the Warrants, shall have been approved for listing on the Exchange, subject only to official notice of issuance.
On the first Option Closing Date (if any), the Company&rsquo;s shares of Common Stock, including the Option Shares and the Underlying
Shares, and the Option Warrants, shall have been approved for listing on the Exchange, subject only to official notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.2
<U>Company Counsel Matters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.1.
<U>Closing Date Opinion of Counsel</U>. On the Closing Date, the Representative shall have received the favorable opinion and negative
assurance letter of Golenbock Eiseman Assor Bell &amp; Peskoe LLP, counsel to the Company, dated the Closing Date and addressed to the
Representative, in form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.2.
<U>[Reserved]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.3.
<U>Option Closing Date Opinion of Counsel</U>. On the Option Closing Date, if any, the Representative shall have received the favorable
opinions of each counsel listed in Section 4.2.1, dated the Option Closing Date, addressed to the Representative and in form and substance
reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the statements made by such counsel in its opinion
delivered on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2.4.
<U>Reliance</U>. In rendering such opinions, such counsel may rely: (i) as to matters involving the application of laws other than the
laws of the United States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified
in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Representative) of other
counsel reasonably acceptable to the Representative, familiar with the applicable laws; and (ii) as to matters of fact, to the extent
they deem proper, on certificates or other written statements of officers of the Company and officers of departments of various jurisdictions
having custody of documents respecting the corporate existence or good standing of the Company, provided that copies of any such statements
or certificates shall be delivered to Representative Counsel if requested. The opinions of each counsel listed in Section 4.2.1, and
any opinion relied upon by such counsel shall include a statement to the effect that it may be relied upon by Representative Counsel
in its opinion delivered to the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.3
<U>Comfort Letters</U>. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.3.1.
<U>Cold Comfort Letter</U>. At the time this Agreement is executed you shall have received a cold comfort letter from the Auditor containing
statements and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements
and certain financial information contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus, addressed
to the Representative and in form and substance satisfactory in all respects to you and to the Auditor, dated as of the date of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.3.2.
<U>Bring-down Comfort Letter</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received
from the Auditor a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that the Auditor reaffirms
the statements made in the letter furnished pursuant to Section 4.3.1, except that the specified date referred to shall be a date not
more than three (3) Business Days prior to the Closing Date or the Option Closing Date, as applicable. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.4
<U>Officers&rsquo; Certificates</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.4.1.
<U>Officers&rsquo; Certificate</U>. The Company shall have furnished to the Representative a certificate, dated the Closing Date and
any Option Closing Date (if such date is other than the Closing Date), of its Chief Executive Officer, its President and its Chief Financial
Officer stating on behalf of the Company and not in an individual capacity that (i) such officers have carefully examined the Registration
Statement, the Pricing Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and, in their opinion, the Registration
Statement and each amendment thereto, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date is
other than the Closing Date) did not include any untrue statement of a material fact and did not omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading, and the Pricing Disclosure Package, as of the Applicable
Time and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), any Issuer Free Writing Prospectus
as of its date and as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date), the Prospectus and
each amendment or supplement thereto, as of the respective date thereof and as of the Closing Date, did not include any untrue statement
of a material fact and did not omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
in which they were made, not misleading, (ii) since the effective date of the Registration Statement, no event has occurred which should
have been set forth in a supplement or amendment to the Registration Statement, the Pricing Disclosure Package or the Prospectus, (iii)
to the best of their knowledge after reasonable investigation, as of the Closing Date (or any Option Closing Date if such date is other
than the Closing Date), the representations and warranties of the Company in this Agreement are true and correct and the Company has
complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing
Date (or any Option Closing Date if such date is other than the Closing Date), and (iv) there has not been, subsequent to the date of
the most recent audited financial statements included or incorporated by reference in the Pricing Disclosure Package, any material adverse
change in the financial position or results of operations of the Company, or any change or development that, singularly or in the aggregate,
would involve a material adverse change or a prospective material adverse change, in or affecting the condition (financial or otherwise),
results of operations, business, assets or prospects of the Company, except as set forth in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.4.2.
<U>Secretary&rsquo;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have
received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Closing Date, as the
case may be, respectively, certifying on behalf of the Company and not in an individual capacity: (i) that each of the Charter and Bylaws
is true and complete, has not been modified and is in full force and effect; (ii) that the resolutions of the Company&rsquo;s Board of
Directors relating to the Offering are in full force and effect and have not been modified; (iii) as to the accuracy and completeness
of all correspondence between the Company or its counsel and the Commission; and (iv) as to the incumbency of the officers of the Company.
The documents referred to in such certificate shall be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.5
<U>No Material Changes</U>. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been
no material adverse change or development involving a prospective material adverse change in the condition or prospects or the business
activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration
Statement, the Pricing Disclosure Package and the Prospectus; (ii) no action, suit or proceeding, at law or in equity, shall have been
pending or threatened against the Company or any Insider before or by any court or federal or state commission, board or other administrative
agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business, operations, prospects or financial
condition or income of the Company, except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus;
(iii) no stop order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or threatened
by the Commission; and (iv) the Registration Statement, the Pricing Disclosure Package and the Prospectus and any amendments or supplements
thereto shall contain all material statements which are required to be stated therein in accordance with the Securities Act and the Securities
Act Regulations and shall conform in all material respects to the requirements of the Securities Act and the Securities Act Regulations,
and neither the Registration Statement, the Pricing Disclosure Package nor the Prospectus nor any amendment or supplement thereto shall
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.6
<U>Delivery of Agreements</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.6.1.
<U>Lock-Up Agreements</U>. On or before the date of this Agreement, the Company shall have delivered to the Representative executed copies
of the Lock-Up Agreements from each of the persons listed in <U>Schedule 3</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.6.2.
<U>Warrant Agreement</U>. On or before the Closing Date, the Company shall have delivered to the Representative an executed copy of the
Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.6.3.
<U>Pre-Funded Warrant Certificates</U>. On or before each of the Closing Date and any Option Closing Date, the Company shall have delivered
to the Representative executed copies of the Pre-Funded Warrant Certificates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.6.4.
<U>Representative&rsquo;s Warrant Agreement</U>. On or before each of the Closing Date and any Option Closing Date, the Company shall
have delivered to the Representative an executed copy of the Representative&rsquo;s Warrant Agreement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.7
<U>Additional Documents</U>. At the Closing Date and at each Option Closing Date (if any) Representative Counsel shall have been furnished
with such documents and opinions as they may require for the purpose of enabling Representative Counsel to deliver an opinion to the
Underwriters, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions,
herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Securities and the
Representative&rsquo;s Securities as herein contemplated shall be satisfactory in form and substance to the Representative and Representative
Counsel. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.1
<U>Indemnification of the Underwriters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.1.1.
<U>General</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each Underwriter, its affiliates
and each of its and their respective directors, officers, members, employees, representatives, partners, shareholders, affiliates, counsel,
and agents and each person, if any, who controls any such Underwriter within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act (collectively the &ldquo;Underwriter Indemnified Parties,&rdquo; and each an &ldquo;Underwriter Indemnified Party&rdquo;),
against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and all legal or other expenses
reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever,
whether arising out of any action between any of the Underwriter Indemnified Parties and the Company or between any of the Underwriter
Indemnified Parties and any third party, or otherwise) to which they or any of them may become subject under the Securities Act, the
Exchange Act or any other statute or at common law or otherwise or under the laws of foreign countries (a &ldquo;Claim&rdquo;), (i) arising
out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (A) the Registration Statement,
the Pricing Disclosure Package, any Preliminary Prospectus, the Prospectus, or in any Issuer Free Writing Prospectus or in any Written
Testing-the-Waters Communication (as from time to time each may be amended and supplemented); (B) any materials or information provided
to investors by, or with the approval of, the Company in connection with the marketing of the Offering, including any &ldquo;road show&rdquo;
or investor presentations made to investors by the Company (whether in person or electronically); or (C) any application or other document
or written communication (in this Section 5, collectively called &ldquo;application&rdquo;) executed by the Company or based upon written
information furnished by the Company in any jurisdiction in order to qualify the Public Securities and Representative&rsquo;s Securities
under the securities laws thereof or filed with the Commission, any state securities commission or agency, the Exchange or any other
national securities exchange; or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, unless such statement or
omission was made in reliance upon, and in conformity with, the Underwriters&rsquo; Information or (ii) otherwise arising in connection
with or allegedly in connection with the Offering. The Company also agrees that it will reimburse each Underwriter Indemnified Party
for all fees and expenses (including but not limited to any and all legal or other expenses reasonably incurred in investigating, preparing
or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action between any
of the Underwriter Indemnified Parties and the Company or between any of the Underwriter Indemnified Parties and any third party, or
otherwise) (collectively, the &ldquo;Expenses&rdquo;), and further agrees wherever and whenever possible to advance payment of Expenses
as they are incurred by an Underwriter Indemnified Party in investigating, preparing, pursuing or defending any Claim. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.1.2.
<U>Procedure</U>. If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought against
the Company pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing of the institution
of such action and the Company shall assume the defense of such action, including the employment and fees of counsel (subject to the
approval of such Underwriter Indemnified Party) and payment of actual expenses if an Underwriter Indemnified Party requests that the
Company do so. Such Underwriter Indemnified Party shall have the right to employ its or their own counsel in any such case, but the fees
and expenses of such counsel shall be at the expense of the Company and shall be advanced by the Company. The Company shall not be liable
for any settlement of any action effected without its consent (which shall not be unreasonably withheld). In addition, the Company shall
not, without the prior written consent of the Underwriters, settle, compromise or consent to the entry of any judgment in or otherwise
seek to terminate any pending or threatened action in respect of which advancement, reimbursement, indemnification or contribution may
be sought hereunder (whether or not such Underwriter Indemnified Party is a party thereto) unless such settlement, compromise, consent
or termination (i) includes an unconditional release of each Underwriter Indemnified Party, acceptable to such Underwriter Indemnified
Party, from all liabilities, expenses and claims arising out of such action for which indemnification or contribution may be sought and
(ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any Underwriter
Indemnified Party.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.2
<U>Indemnification of the Company</U>. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company,
its directors, its officers who signed the Registration Statement and persons who control the Company within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the
foregoing indemnity from the Company to the several Underwriters, as incurred, but only with respect to untrue statements or omissions
made in the Registration Statement, any Preliminary Prospectus, the Pricing Disclosure Package or Prospectus or any amendment or supplement
thereto or in any application, in reliance upon, and in strict conformity with, the Underwriters&rsquo; Information. In case any action
shall be brought against the Company or any other person so indemnified based on any Preliminary Prospectus, the Registration Statement,
the Pricing Disclosure Package or Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity
may be sought against any Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each
other person so indemnified shall have the rights and duties given to the several Underwriters by the provisions of Section 5.1.2. The
Company agrees promptly to notify the Representative of the commencement of any litigation or proceedings against the Company or any
of its officers, directors or any person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, in connection with the issuance and sale of the Public Securities or in connection with the Registration
Statement, the Pricing Disclosure Package, the Prospectus, or any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.3
<U>Contribution</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.3.1.
<U>Contribution Rights</U>. If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient
to hold harmless an indemnified party under Section 5.1 or 5.2 in respect of any loss, claim, damage or liability, or any action in respect
thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount
paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in
such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters,
on the other, from the Offering of the Public Securities, or (ii) if the allocation provided by clause (i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also
the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that
resulted in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations.
The relative benefits received by the Company, on the one hand, and the Underwriters, on the other, with respect to such Offering shall
be deemed to be in the same proportion as the total net proceeds from the Offering of the Public Securities purchased under this Agreement
(before deducting expenses) received by the Company, as set forth in the table on the cover page of the Prospectus, on the one hand,
and the total underwriting discounts and commissions received by the Underwriters with respect to the shares of the Common Stock purchased
under this Agreement, as set forth in the table on the cover page of the Prospectus, on the other hand. The relative fault shall be determined
by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access
to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would
not be just and equitable if contributions pursuant to this Section 5.3.1 were to be determined by pro rata allocation (even if the Underwriters
were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable considerations
referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action
in respect thereof, referred to above in this Section 5.3.1 shall be deemed to include, for purposes of this Section 5.3.1, any legal
or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this Section 5.3.1 in no event shall an Underwriter be required to contribute any amount in excess
of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the Offering of
the Public Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue
or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.3.2.
<U>Contribution Procedure</U>. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice
of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made
against another party (&ldquo;contributing party&rdquo;), notify the contributing party of the commencement thereof, but the failure
to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or
its representative of the commencement thereof within the aforesaid 15 days, the contributing party will be entitled to participate therein
with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any
party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
on account of any settlement of any claim, action or proceeding affected by such party seeking contribution without the written consent
of such contributing party. The contribution provisions contained in this Section 5.3.2 are intended to supersede, to the extent permitted
by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available. Each Underwriter&rsquo;s obligations
to contribute pursuant to this Section 5.3 are several and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">6.
<U>Default by an Underwriter</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">6.1
<U>Default Not Exceeding 10% of Firm Securities or Option Securities</U>. If any Underwriter or Underwriters shall default in its or
their obligations to purchase the Firm Securities or the Option Securities, if the Over-allotment Option is exercised hereunder, and
if the number of the Firm Securities or Option Securities with respect to which such default relates does not exceed in the aggregate
10% of the number of Firm Securities or Option Securities that all Underwriters have agreed to purchase hereunder, then such Firm Securities
or Option Securities to which the default relates shall be purchased by the non-defaulting Underwriters in proportion to their respective
commitments hereunder.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">6.2
<U>Default Exceeding 10% of Firm Securities or Option Securities</U>. In the event that the default addressed in Section 6.1 relates
to more than 10% of the Firm Securities or Option Securities, you may in your discretion arrange for yourself or for another party or
parties to purchase such Firm Securities or Option Securities to which such default relates on the terms contained herein. If, within
one (1) Business Day after such default relating to more than 10% of the Firm Securities or Option Securities, you do not arrange for
the purchase of such Firm Securities or Option Securities, then the Company shall be entitled to a further period of one (1) Business
Day within which to procure another party or parties satisfactory to you to purchase said Firm Securities or Option Securities on such
terms. In the event that neither you nor the Company arrange for the purchase of the Firm Securities or Option Securities to which a
default relates as provided in this Section 6, this Agreement will automatically be terminated by you or the Company without liability
on the part of the Company (except as provided in Sections 3.10 and 5 hereof) or the several Underwriters (except as provided in Section
5 hereof); provided, however, that if such default occurs with respect to the Option Securities, this Agreement will not terminate as
to the Firm Securities; and provided, further, that nothing herein shall relieve a defaulting Underwriter of its liability, if any, to
the other Underwriters and to the Company for damages occasioned by its default hereunder.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">6.3
<U>Postponement of Closing Date</U>. In the event that the Firm Securities or Option Securities to which the default relates are to be
purchased by the non-defaulting Underwriters, or are to be purchased by another party or parties as aforesaid, you or the Company shall
have the right to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any event exceeding five (5) Business
Days, in order to effect whatever changes may thereby be made necessary in the Registration Statement, the Pricing Disclosure Package
or the Prospectus or in any other documents and arrangements, and the Company agrees to file promptly any amendment to the Registration
Statement, the Pricing Disclosure Package or the Prospectus that in the opinion of Representative Counsel may thereby be made necessary.
The term &ldquo;Underwriter&rdquo; as used in this Agreement shall include any party substituted under this Section 6 with like effect
as if it had originally been a party to this Agreement with respect to such Securites.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">7.
<U>Additional Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">7.1
<U>Board Composition and Board Designations</U>. The Company shall ensure that: (i) the qualifications of the persons serving as members
of the Board of Directors and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act, with the Exchange
Act and with the listing rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company
seeks to have its Public Securities listed on another exchange or quoted on an automated quotation system, and (ii) if applicable, at
least one member of the Audit Committee of the Board of Directors qualifies as an &ldquo;audit committee financial expert,&rdquo; as
such term is defined under Regulation S-K and the listing rules of the Exchange.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">7.2
<U>Prohibition on Press Releases and Public Announcements</U>. The Company shall not issue press releases or engage in any other publicity,
without the Representative&rsquo;s prior written consent, for a period ending at 5:00 p.m., Eastern time, on the first (1<SUP>st</SUP>)
Business Day following the forty-fifth (45<SUP>th</SUP>) day after the Closing Date, other than normal and customary releases issued
in the ordinary course of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">7.3
<U>Right of First Refusal</U>. Provided that the Firm Shares are sold in accordance with the terms of this Agreement, the Representative
shall have an irrevocable right of first refusal (the &ldquo;Right of First Refusal&rdquo;), for a period of eighteen (18) months after
the date the Offering is completed, to act as sole and exclusive investment banker, sole and exclusive book-runner, sole and exclusive
financial advisor, sole and exclusive underwriter and/or sole and exclusive placement agent, at the Representative&rsquo;s sole and exclusive
discretion, for each and every future public and private equity and debt offering, including all equity linked financings (each, a &ldquo;Subject
Transaction&rdquo;), during such eighteen (18) month period, of the Company, or any successor to or subsidiary of the Company, on terms
and conditions customary to the Representative for such Subject Transactions. For the avoidance of any doubt, the Company shall not retain,
engage or solicit any additional investment banker, book-runner, financial advisor, underwriter and/or placement agent in a Subject Transaction
without the express written consent of the Representative.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall notify the Representative of its intention to pursue a Subject Transaction, including the material terms thereof, by providing
written notice thereof by registered mail or overnight courier service addressed to the Representative. If the Representative fails to
exercise its Right of First Refusal with respect to any Subject Transaction within ten (10) Business Days after the mailing of such written
notice, then the Representative shall have no further claim or right with respect to the Subject Transaction. The Representative may
elect, in its sole and absolute discretion, not to exercise its Right of First Refusal with respect to any Subject Transaction; provided
that any such election by the Representative shall not adversely affect the Representative&rsquo;s Right of First Refusal with respect
to any other Subject Transaction during the eighteen (18) month period agreed to above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">8.
<U>Effective Date of this Agreement and Termination Thereof</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.1
<U>Effective Date</U>. This Agreement shall become effective when both the Company and the Representative have executed the same and
delivered counterparts of such signatures to the other party.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.2
<U>Termination</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i) if
any domestic or international event or act or occurrence has materially disrupted, or in your opinion will in the immediate future materially
disrupt, general securities markets in the United States; or (ii) if trading on the New York Stock Exchange or the Nasdaq Stock Market
LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges
for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction;
or (iii) if the United States shall have become involved in a new war or an increase in major hostilities; or (iv) if a banking moratorium
has been declared by a New York State or federal authority; or (v) if a moratorium on foreign exchange trading has been declared which
materially adversely impacts the United States securities markets; or (vi) if the Company shall have sustained a material loss by fire,
flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have
been insured, will, in your opinion, make it inadvisable to proceed with the delivery of the Firm Securities or Option Securities; or
(vii) if the Company is in material breach of any of its representations, warranties or covenants hereunder; or (viii) if the Representative
shall have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such
adverse material change in general market conditions as in the Representative&rsquo;s judgment would make it impracticable to proceed
with the offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale of the
Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.3
<U>Expenses</U>. Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, pursuant
to Section 6.2 above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified
herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters their actual
and accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable (including the fees and disbursements
of Representative Counsel) up to $150,000, and upon demand the Company shall pay the full amount thereof to the Representative on behalf
of the Underwriters; provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions
of this Agreement. Notwithstanding the foregoing, any advance received by the Representative will be reimbursed to the Company to the
extent not actually incurred in compliance with FINRA Rule 5110(g)(4)(A).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.4
<U>Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination
of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in full force
and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this Agreement
or any part hereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">8.5
<U>Representations, Warranties, Agreements to Survive</U>. All representations, warranties and agreements contained in this Agreement
or in certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless
of (i) any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter,
its officers or directors or any person controlling the Company or (ii) delivery of and payment for the Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">9.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.1
<U>Notices</U>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed
(registered or certified mail, return receipt requested), personally delivered or sent by facsimile transmission and confirmed and shall
be deemed given when so delivered or faxed and confirmed or if mailed, two (2) days after such mailing.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Representative:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ThinkEquity
LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 22<SUP>nd</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10004<BR>
Attn: Mr. Eric Lord, Head of Investment Banking</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
(212) 349-2550</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dentons
US LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1221
Avenue of the Americas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Rob Condon, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
(212) 768-6800</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
Industries Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">385
South Pierce Avenue, Suite C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louisville,
Colorado 80027</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Anthony K. McDonald, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Golenbock
Eiseman Assor Bell &amp; Peskoe LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">711
Third Avenue, 17th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Andrew Hudders, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.2
<U>Headings</U>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.3
<U>Amendment</U>. This Agreement may only be amended by a written instrument executed by each of the parties hereto.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.4
<U>Entire Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection
with this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof. Notwithstanding
anything to the contrary set forth herein, it is understood and agreed by the parties hereto that all other terms and conditions of that
certain engagement letter between the Company and ThinkEquity, a division of Fordham Financial Management, Inc., dated July 15, 2021,
shall remain in full force and effect.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.5
<U>Binding Effect</U>. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters,
the Company and the controlling persons, directors and officers referred to in Section 5 hereof, and their respective successors, legal
representatives, heirs and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim
under or in respect of or by virtue of this Agreement or any provisions herein contained. The term &ldquo;successors and assigns&rdquo;
shall not include a purchaser, in its capacity as such, of securities from any of the Underwriters.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.6
<U>Governing Law; Consent to Jurisdiction; Trial by Jury</U>. This Agreement shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that
any action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in
the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in
Section 9.1 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company agrees that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies)
all of its reasonable attorneys&rsquo; fees and expenses relating to such action or proceeding and/or incurred in connection with the
preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates)
and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.7
<U>Execution in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the
same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall
constitute valid and sufficient delivery thereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">9.8
<U>Waiver, etc</U>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not
be deemed or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision
hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page Follows]</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">If
the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided
below for that purpose, whereupon this letter shall constitute a binding agreement between us.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
    INDUSTRIES INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 222.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmed
    as of the date first written above mentioned, on behalf of itself and as Representative of the several Underwriters named on <U>Schedule
    1</U> hereto:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THINKEQUITY
    LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">URBAN-GRO,
INC. &ndash; UNDERWRITING AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>SCHEDULE 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B><U><BR></U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Underwriter</B></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>Total Number of Firm Securities to be Purchased (Firm Shares, Firm
                                                             Pre-Funded Warrants, Firm Warrants)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Option Securities to be Purchased if the Over-Allotment Option is Fully Exercised (Option Shares, Option Pre-Funded Warrants, Option Warrants)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; width: 56%; text-align: left">ThinkEquity LLC.</TD><TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><B>TOTAL</B></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch. 1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>SCHEDULE 2-A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><B>Pricing Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Number of Firm Shares: [&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Number of Firm Pre-Funded Warrants: [&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Number of Firm Warrants: [&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Number of Option Shares: Up to [&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Number of Option Pre-Funded Warrants: Up t o [&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Number of Option Warrants: Up to [&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Public Offering Price per Firm Share: $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Public Offering Price per Firm Pre-Funded Warrant: $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Public Offering Price per Firm Warrant: $0.00001</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Underwriting Discount per Firm Share: $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Underwriting Discount per Firm Pre-Funded Warrant; $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Underwriting Discount per Firm Warrant: $0.0000007</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Underwriting Non-accountable expense allowance per Firm Share: $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Underwriting Non-accountable expense allowance per Firm Pre-Funded Warrant:
$[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Underwriting Non-accountable expense allowance per Firm Warrant: $0.0000001</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Proceeds to Company per Firm Share (before expenses): $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Proceeds to Company per Firm Pre-Funded Warrant (before expenses): $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Proceeds to Company per Firm Warrant (before expenses): $[&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>SCHEDULE 2-B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Issuer General Use Free Writing Prospectuses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>SCHEDULE 2-C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Written Testing-the-Waters Communications</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch. 2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>SCHEDULE 3</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>List of Lock-Up Parties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Anthony K. McDonald</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">James R. Shipley</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nicholas J. Etten</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Marion Mariathasan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Troy L Reisner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Brian Knaley</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">John F. Jansen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Evergreen Capital Management LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Sch. 3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form of Pre-Funded Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form of Representative&rsquo;s Warrant Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt">THE REGISTERED HOLDER OF THIS
PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED
AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE
WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) THINKEQUITY LLC
OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF THINKEQUITY LLC OR OF
ANY SUCH UNDERWRITER OR SELECTED DEALER.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.2pt">THIS PURCHASE WARRANT IS NOT EXERCISABLE
PRIOR TO [________________] [<B>DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING</B>]. VOID AFTER 5:00 P.M., EASTERN TIME,
[___________________] [<B>DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING</B>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WARRANT TO PURCHASE COMMON STOCK </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CEA INDUSTRIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Warrant Shares: _______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Initial Exercise Date: ______, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">THIS WARRANT TO PURCHASE COMMON
STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
____, 2022 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New
York time) on the date that is five (5) years following the Effective Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter,
to subscribe for and purchase from CEA Industries Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares of
Common Stock, par value $0.0001 per share, of the Company (the &ldquo;<U>Warrant Shares</U>&rdquo;), as subject to adjustment hereunder.
The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking
institutions in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; means the effective date of the registration statement on Form S-1 (File No. 333-261648), including any related prospectus
or prospectuses, for the registration of the Company&rsquo;s common stock, par value $0.0001 per share, pre-funded warrants, warrants,
shares of common stock underlying pre-funded warrants and warrants, Warrants and the Warrant Shares under the Securities Act, that the
Company has filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the Nasdaq Capital Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed or quoted
on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the
Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if Common Stock is not
then listed or quoted for trading on the OTCQB or OTCQX and if prices for Common Stock are then reported in the &ldquo;Pink Sheets&rdquo;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent
bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of the Common Stock as determined by
an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">a) Exercise of the purchase
rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on
or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice
in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy
(or e-mail attachment) of the Notice of Exercise Form annexed hereto. Within two (2) Trading Days following the date of exercise as aforesaid,
the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or
cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified
in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder
shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available
hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation
within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise Form within two (2) Business Days of receipt of such notice. <B>The Holder and any assignee, by
acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion
of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the
amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise Price</U>.
The exercise price per share of the Common Stock under this Warrant shall be <B>$_______</B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>,
subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier&rsquo;s check, at the election
of the Holder this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 1in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.35in">(A) = </TD>
    <TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP></FONT>125% of the public offering price per share of common stock in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 1in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.35in">(B) = </TD>
    <TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(X) = </TD>
    <TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a &ldquo;cashless exercise,&rdquo; the parties acknowledge and agree that in accordance with Section
3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the
holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to
take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding anything
herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this
Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.2in">i. <U>Delivery of Warrant
Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by its transfer agent to the
Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder,
or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 and,
in either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share Delivery Date (as defined below), and otherwise
by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for
the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice
of Exercise by the date that is two (2) Trading Days after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant
Share Delivery Date</U>&rdquo;). If the Warrant Shares can be delivered via DWAC, the transfer agent shall have received from the Company,
at the expense of the Company, any legal opinions or other documentation required by it to deliver such Warrant Shares without legend
(subject to receipt by the Company of reasonable back up documentation from the Holder, including with respect to affiliate status) and,
if applicable and requested by the Company prior to the Warrant Share Delivery Date, the transfer agent shall have received from the Holder
a confirmation of sale of the Warrant Shares (provided the requirement of the Holder to provide a confirmation as to the sale of Warrant
Shares shall not be applicable to the issuance of unlegended Warrant Shares upon a cashless exercise of this Warrant if the Warrant Shares
are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be deemed to have been issued, and Holder or any other
person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the
date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all
taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to the issuance of such shares, having been paid.
If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the second Trading
Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue)
for each Trading Day after the second Trading Day following such Warrant Share Delivery Date until such Warrant Shares are delivered or
Holder rescinds such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.2in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">ii. <U>Delivery of
New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon
surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the
rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">iii. <U>Rescission
Rights</U>. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant to Section 2(d)(i) by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; <U>provided</U>, <U>however</U>, that the
Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise notice concurrently with
the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder&rsquo;s
right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such
restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise on or before the Warrant
Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise)
or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of
the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A)
pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if
any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that
the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant
and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded)
or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover
a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">vi. <U>Charges, Taxes
and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all transfer agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">vii. <U>Closing of
Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">viii. <U>Signature</U>.
This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the Holder in order to exercise
this Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required, nor shall any medallion guarantee
(or other type of guarantee or notarization) of any exercise form be required in order to exercise this Warrant. No additional legal opinion,
other information or instructions shall be required of the Holder to exercise this Warrant. The Company shall honor exercises of this
Warrant and shall deliver Warrant Shares underlying this Warrant in accordance with the terms, conditions and time periods set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates), would beneficially own in excess of the Beneficial Ownership
Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the
Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which
such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of
the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole
discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of
this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to
verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company&rsquo;s
transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company
shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The
Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided
that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this
Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP>
day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification. For the purposes of clarification, the Exercise Price of this Warrant will not be adjusted in the event
that the Company or any Subsidiary thereof, as applicable, sells or grants any option to purchase, or sell or grant any right to reprice,
or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock
or Common Stock Equivalents, at an effective price per share less than the Exercise Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">b) [RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent Rights
Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common
Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares
of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to
such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale
of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right to participate in
any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than cash dividends) or other
distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of shares or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion
of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Fundamental Transaction</U>.
If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease,
license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related
transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person)
is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash
or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or
(v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including
any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable by holders of Common Stock as a result of such Fundamental Transaction for each share of Common Stock for which this Warrant
is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of
this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to
such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements
in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo; shall
refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">i. <U>Adjustment to
Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail
to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares
and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1.75in">ii. <U>Notice to Allow
Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class
or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets
of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E)
the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in
each case, the Company shall cause to be mailed a notice to the Holder at its last address as it shall appear upon the Warrant Register
of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, stating (x) the date
on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not
to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share
exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record
shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to provide such notice or any defect therein shall
not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Pursuant to FINRA Rule 5110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred,
assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result
in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness
or commencement of sales of the offering pursuant to which this Warrant is being issued, except the transfer of any security:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in">i. by operation of law
or by reason of reorganization of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in">ii. to any FINRA member
firm participating in the offering and the officers or partners thereof, if all securities so transferred remain subject to the lock-up
restriction in this Section 4(a) for the remainder of the time period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in">iii. if the aggregate amount
of securities of the Company held by the Holder or related person do not exceed 1% of the securities being offered;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in">iv. that is beneficially
owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages or otherwise directs
investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in the fund; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in">v. the exercise or conversion
of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">Subject to the foregoing
restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly
executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue
to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date the Holder delivers an assignment form to the Company assigning this Warrant full. The Warrant, if properly assigned in accordance
herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 5. Registration Rights.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>5.1.</U> <U>Demand Registration</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.1.1 Grant of Right.
The Company, upon written demand (a &ldquo;Demand Notice&rdquo;) of the Holder(s) of at least 51% of the Warrants and/or the underlying
Warrant Shares, agrees to register, on one occasion, all or any portion of the Warrant Shares underlying the Warrants (collectively, the
&ldquo;Registrable Securities&rdquo;). On such occasion, the Company will file a registration statement with the Commission covering the
Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its reasonable best efforts to have the registration
statement declared effective promptly thereafter, subject to compliance with review by the Commission; provided, however, that the Company
shall not be required to comply with a Demand Notice if the Company has filed a registration statement with respect to which the Holder
is entitled to piggyback registration rights pursuant to Section 5.2 hereof and either: (i) the Holder has elected to participate in the
offering covered by such registration statement or (ii) if such registration statement relates to an underwritten primary offering of
securities of the Company, until the offering covered by such registration statement has been withdrawn or until thirty (30) days after
such offering is consummated. The demand for registration may be made at any time beginning on the Initial Exercise Date and expiring
on the fifth anniversary of the Effective Date. The Company covenants and agrees to give written notice of its receipt of any Demand Notice
by any Holder(s) to all other registered Holders of the Warrants and/or the Registrable Securities within ten (10) days after the date
of the receipt of any such Demand Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.1.2 Terms. The Company
shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section 5.1.1, but the Holders
shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them in connection
with the sale of the Registrable Securities. The Company agrees to use its reasonable best efforts to cause the filing required herein
to become effective promptly and to qualify or register the Registrable Securities in such States as are reasonably requested by the Holder(s);
provided, however, that in no event shall the Company be required to register the Registrable Securities in a State in which such registration
would cause: (i) the Company to be obligated to register or license to do business in such State or submit to general service of process
in such State, or (ii) the principal shareholders of the Company to be obligated to escrow their shares of capital stock of the Company.
The Company shall cause any registration statement filed pursuant to the demand right granted under Section 5.1.1 to remain effective
for a period of at least twelve (12) consecutive months after the date that the Holders of the Registrable Securities covered by such
registration statement are first given the opportunity to sell all of such securities. The Holders shall only use the prospectuses provided
by the Company to sell the Warrant Shares covered by such registration statement, and will immediately cease to use any prospectus furnished
by the Company if the Company advises the Holder that such prospectus may no longer be used due to a material misstatement or omission.
Notwithstanding the provisions of this Section 5.1.2, the Holder shall be entitled to a demand registration under this Section 5.1.2 on
only one (1) occasion and such demand registration right shall terminate on the fifth anniversary of the date of the Underwriting Agreement
(as defined below) in accordance with FINRA Rule 5110(g)(8)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><U>5.2</U> &nbsp;<U>&ldquo;Piggy-Back&rdquo; Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.2.1 Grant of Right.
In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have the right, for a period of no more
than two (2) years from the Initial Exercise Date in accordance with FINRA Rule 5110(g)(8)(D), to include the Registrable Securities as
part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated by Rule 145(a)
promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however, that if, solely in connection
with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable
discretion, impose a limitation on the number of Warrant Shares which may be included in the Registration Statement because, in such underwriter(s)&rsquo;
judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be
obligated to include in such Registration Statement only such limited portion of the Registrable Securities with respect to which the
Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable Securities shall be made
pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities sought to be
included by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless the Company has first
excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such Registration Statement
or are not entitled to pro rata inclusion with the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.2.2 Terms. The Company
shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 5.2.1 hereof, but the Holders
shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them in connection
with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish the then Holders
of outstanding Registrable Securities with not less than thirty (30) days&rsquo; written notice prior to the proposed date of filing of
such registration statement. Such notice to the Holders shall continue to be given for each registration statement filed by the Company
during the two (2) year period following the Initial Exercise Date until such time as all of the Registrable Securities have been sold
by the Holder. The holders of the Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving
written notice within ten (10) days of the receipt of the Company&rsquo;s notice of its intention to file a registration statement. Except
as otherwise provided in this Warrant, there shall be no limit on the number of times the Holder may request registration under this Section
5.2.2; provided, however, that such registration rights shall terminate on the second anniversary of the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><U>5.3</U>&nbsp; <U>General Terms</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.3.1 Indemnification.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and
each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a) of the Exchange
Act against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably
incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under the Securities
Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the same effect as the
provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section 5.1 of the underwriting agreement,
dated [ ], 2022, by and between the Company and ThinkEquity LLC, as representative of the underwriters set forth therein (the &ldquo;Underwriting
Agreement&rdquo;). The Holder(s) of the Registrable Securities to be sold pursuant to such registration statement, and their successors
and assigns, shall severally, and not jointly, indemnify the Company, against all loss, claim, damage, expense or liability (including
all reasonable attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing or defending against any claim
whatsoever) to which they may become subject under the Securities Act, the Exchange Act or otherwise, arising from information furnished
by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion in such registration statement to
the same extent and with the same effect as the provisions contained in Section 5.2 of the Underwriting Agreement pursuant to which the
Underwriters have agreed to indemnify the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.3.2 Exercise of Warrants.
Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants prior to or after the initial
filing of any registration statement or the effectiveness thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.3.3 Documents Delivered
to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each underwriter of any such
offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel to the Company, dated the
effective date of such registration statement (and, if such registration includes an underwritten public offering, an opinion dated the
date of the closing under any underwriting agreement related thereto), and (ii) a &ldquo;cold comfort&rdquo; letter dated the effective
date of such registration statement (and, if such registration includes an underwritten public offering, a letter dated the date of the
closing under the underwriting agreement) signed by the independent registered public accounting firm which has issued a report on the
Company&rsquo;s financial statements included in such registration statement, in each case covering substantially the same matters with
respect to such registration statement (and the prospectus included therein) and, in the case of such accountants&rsquo; letter, with
respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer&rsquo;s counsel
and in accountants&rsquo; letters delivered to underwriters in underwritten public offerings of securities. The Company shall also deliver
promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to the managing
underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all memoranda relating
to discussions with the Commission or its staff with respect to the registration statement and permit each Holder and underwriter to do
such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the registration statement
as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access
to books, records and properties and opportunities to discuss the business of the Company with its officers and independent auditors,
all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.3.4 Underwriting Agreement.
The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any Holders whose Registrable
Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably satisfactory to the Company.
Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such managing underwriters, and
shall contain such representations, warranties and covenants by the Company and such other terms as are customarily contained in agreements
of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating to an underwritten
sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties and covenants of
the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such Holders shall not
be required to make any representations or warranties to or agreements with the Company or the underwriters except as they may relate
to such Holders, their Warrant Shares and their intended methods of distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.3.5 Documents to be
Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company a completed
and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">5.3.6 Damages. Should
the registration or the effectiveness thereof required by Sections 5.1 and 5.2 hereof be delayed by the Company or the Company otherwise
fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s),
be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions
or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other
security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 6</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No Rights as Stockholder
Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company
prior to the exercise hereof as set forth in Section 2(d)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss, Theft, Destruction
or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting
of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver
a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">The Company covenants that,
during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares
to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary
Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be
necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or
of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which
may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">Except and to the extent
as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">Before taking any action
which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, or otherwise able to be
resold or transferred without restriction pursuant to an exemption from registration under the Securities Act, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver and
Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver
of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant
or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>. Any
notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance
with the notice provisions of the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation of
Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors and
Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit
of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>CEA InDUSTRIES INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="text-transform: uppercase">TO:
CEA INDUSTRIES Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">_________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify">[&nbsp;&nbsp;] in lawful money of the United States;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify">[&nbsp;&nbsp;] if permitted the cancellation of such
number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect
to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(3) Please register and issue said
Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number or by physical delivery of a certificate to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>.
If the Warrant is being exercised via cash exercise, the undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation
D promulgated under the Securities Act of 1933, as amended</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Name of Investing Entity: _________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Signature of Authorized Signatory of Investing Entity</I>: ___________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Name of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Title of Authorized Signatory: ______________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: _________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(To assign the foregoing warrant, execute<BR>
this form and supply required information.<BR>
Do not use this form to exercise the warrant.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">FOR VALUE RECEIVED, [____] all of
or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">_______________________________________________ whose
address is</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">_______________________________________________________________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">_______________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in">Dated: ______________,
_______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Holder&rsquo;s Signature: _____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Holder&rsquo;s Address: _____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify; text-indent: 0.5in">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NOTE: The signature to this Assignment Form must correspond
with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever. Officers of corporations
and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Lock-Up Agreement<BR>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">[&#9679;], 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">ThinkEquity LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">17 State Street, 22<SUP>nd</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New York, NY 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As Representative of the several Underwriters named on Schedule 1 to the
Underwriting Agreement referenced below<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned understands that
ThinkEquity LLC (the &ldquo;<B>Representative</B>&rdquo;), proposes to enter into an Underwriting Agreement (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;) with CEA Industries Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), providing for the public offering
(the &ldquo;<B>Public Offering</B>&rdquo;) of securities including shares of common stock, par value $0.00001 per share, of the Company
(the &ldquo;<B>Common Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">To induce the Representative to
continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent of
the Representative, the undersigned will not, during the period commencing on the date hereof and ending [90/180]<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT>
days after the date of the Underwriting Agreement relating to the Public Offering (the &ldquo;<B>Lock-Up Period</B>&rdquo;), (1) offer,
pledge, sell, contract to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any Common Shares or any securities
convertible into or exercisable or exchangeable for Common Shares, whether now owned or hereafter acquired by the undersigned or with
respect to which the undersigned has or hereafter acquires the power of disposition (collectively, the &ldquo;<B>Lock-Up Securities</B>&rdquo;);
(2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Lock-Up Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities,
in cash or otherwise; (3) make any demand for or exercise any right with respect to the registration of any Lock-Up Securities; or (4)
publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other
arrangement relating to any Lock-Up Securities. Notwithstanding the foregoing, and subject to the conditions below, the undersigned may
transfer Lock-Up Securities without the prior written consent of the Representative in connection with (a) transactions relating to Lock-Up
Securities acquired in open market transactions after the completion of the Public Offering; <U>provided</U> that no filing under Section
13 or Section 16(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), or other public announcement
shall be required or shall be voluntarily made in connection with subsequent sales of Lock-Up Securities acquired in such open market
transactions; (b) transfers of Lock-Up Securities as a <I>bona fide</I> gift, by will or intestacy or to a family member or trust for
the benefit of the undersigned or a family member (for purposes of this lock-up agreement, &ldquo;family member&rdquo; means any relationship
by blood, marriage or adoption, not more remote than first cousin); (c) transfers of Lock-Up Securities to a charity or educational institution;
(d) if the undersigned is a corporation, partnership, limited liability company or other business entity, (i) any transfers of Lock-Up
Securities to another corporation, partnership or other business entity that controls, is controlled by or is under common control with
the undersigned or (ii) distributions of Lock-Up Securities to members, partners, stockholders, subsidiaries or affiliates (as defined
in Rule 405 promulgated under the Securities Act of 1933, as amended) of the undersigned; (e) if the undersigned is a trust, to a trustee
or beneficiary of the trust; <U>provided</U> that in the case of any transfer pursuant to the foregoing clauses (b), (c) (d) or (e), (i)
any such transfer shall not involve a disposition for value, (ii) each transferee shall sign and deliver to the Representative a lock-up
agreement substantially in the form of this lock-up agreement and (iii) no filing under Section 13 or Section 16(a) of the Exchange Act
or other public announcement shall be required or shall be voluntarily made; (f) the receipt by the undersigned from the Company of Common
Shares upon the vesting of restricted stock awards or stock units or upon the exercise of options to purchase the Company&rsquo;s Common
Shares issued under an equity incentive plan of the Company or an employment arrangement described in the Pricing Prospectus (as defined
in the Underwriting Agreement) (the &ldquo;<B>Plan Shares</B>&rdquo;) or the transfer of Common Shares or any securities convertible into
Common Shares to the Company upon a vesting event of the Company&rsquo;s securities or upon the exercise of options to purchase the Company&rsquo;s
securities, in each case on a &ldquo;cashless&rdquo; or &ldquo;net exercise&rdquo; basis or to cover tax obligations of the undersigned
in connection with such vesting or exercise, but only to the extent such right expires during the Lock-up Period, <U>provided</U> that
no filing under Section 13 or Section 16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily
made within [90/180] days after the date of the Underwriting Agreement, and after such [90/180]<SUP>th</SUP> day, if the undersigned is
required to file a report under Section 13 or Section 16(a) of the Exchange Act reporting a reduction in beneficial ownership of Common
Shares during the Lock-Up Period, the undersigned shall include a statement in such schedule or report to the effect that the purpose
of such transfer was to cover tax withholding obligations of the undersigned in connection with such vesting or exercise and, <U>provided
further</U>, that the Plan Shares shall be subject to the terms of this lock-up agreement; (g) the establishment of a trading plan pursuant
to Rule 10b5-1 under the Exchange Act for the transfer of Lock-Up Securities, <U>provided</U> that (i) such plan does not provide for
the transfer of Lock-Up Securities during the Lock-Up Period and (ii) to the extent a public announcement or filing under the Exchange
Act, if any, is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such
plan, such public announcement or filing shall include a statement to the effect that no transfer of Lock-Up Securities may be made under
such plan during the Lock-Up Period; (h) the conversion of the outstanding preferred stock of the Company into Common Shares, provided
that such Common Shares remain subject to the terms of this agreement; (i) the transfer of Lock-Up Securities that occurs by operation
of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement, <U>provided</U> that the transferee
agrees to sign and deliver a lock-up agreement substantially in the form of this lock-up agreement for the balance of the Lock-Up Period,
and <U>provided further</U>, that any filing under Section 13 or Section 16(a) of the Exchange Act that is required to be made during
the Lock-Up Period as a result of such transfer shall include a statement that such transfer has occurred by operation of law; and (j)
the transfer of Lock-Up Securities pursuant to a bona fide third party tender offer, merger, consolidation or other similar transaction
made to all holders of the Common Shares involving a change of control (as defined below) of the Company after the closing of the Public
Offering and approved by the Company&rsquo;s board of directors; <U>provided</U> that in the event that the tender offer, merger, consolidation
or other such transaction is not completed, the Lock-Up Securities owned by the undersigned shall remain subject to the restrictions contained
in this lock-up agreement. For purposes of clause (j) above, &ldquo;change of control&rdquo; shall mean the consummation of any bona fide
third party tender offer, merger, amalgamation, consolidation or other similar transaction the result of which is that any &ldquo;person&rdquo;
(as defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and
13d-5 of the Exchange Act) of a majority of total voting power of the voting stock of the Company. The undersigned also agrees and consents
to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar against the transfer of the undersigned&rsquo;s
Lock-Up Securities except in compliance with this lock-up agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><SUP>2 </SUP>180
days for directors and officers; 90 days for 5% and greater stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If the undersigned is an officer
or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be equally applicable to any issuer-directed
or &ldquo;friends and family&rdquo; securities that the undersigned may purchase in the Public Offering; (ii) the Representative agrees
that, at least three (3) business days before the effective date of any release or waiver of the foregoing restrictions in connection
with a transfer of Lock-Up Securities, the Representative will notify the Company of the impending release or waiver; and (iii) the Company
has agreed in the Underwriting Agreement to announce the impending release or waiver by press release through a major news service at
least two (2) business days before the effective date of the release or waiver. Any release or waiver granted by the Representative hereunder
to any such officer or director shall only be effective two (2) business days after the publication date of such press release. The provisions
of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer of Lock-Up Securities not for consideration
and (b) the transferee has agreed in writing to be bound by the same terms described in this lock-up agreement to the extent and for the
duration that such terms remain in effect at the time of such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned understands that
the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation of the Public Offering. The
undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the undersigned&rsquo;s heirs, legal
representatives, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The undersigned understands that,
if the Underwriting Agreement is not executed by September 30, 2022, or if the Company and the Representative agree to terminate the Public
Offering, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated
prior to payment for and delivery of the Common Shares to be sold thereunder, then this lock-up agreement shall be void and of no further
force or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Whether or not the Public Offering
actually occurs depends on a number of factors, including market conditions. Any Public Offering will only be made pursuant to an Underwriting
Agreement, the terms of which are subject to negotiation between the Company and the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Name - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Name of Signatory, in the case of entities - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(Title of Signatory, in the case of entities - Please Print)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 8%">Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 42%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT D</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form of Press Release</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>CEA INDUSTRIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>[Date]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">CEA Industries Inc. (the &ldquo;Company&rdquo;) announced
today that ThinkEquity LLC, acting as representative for the underwriters in the Company&rsquo;s recent public offering of _______ shares
of the Company&rsquo;s common stock, is [waiving] [releasing] a lock-up restriction with respect to _________ shares of the Company&rsquo;s
common stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver] [release] will take effect
on _________, 20___, and the shares may be sold on or after such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>This press release is not an offer or sale of the
securities in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities may not be offered
or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 28; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>ex4-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&rsquo;s Warrant Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER
THAN (I) THINKEQUITY LLC OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER
OF THINKEQUITY LLC OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [<B>DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING</B>].
VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [<B>DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING</B>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE COMMON STOCK </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CEA
INDUSTRIES INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: _______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Exercise Date: ______, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT TO PURCHASE COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after ____, 2022 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and, in accordance with FINRA Rule 5110(g)(8)(A),
prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from CEA Industries Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
up to ______ shares of Common Stock, par value $0.0001 per share, of the Company (the &ldquo;<U>Warrant Shares</U>&rdquo;), as subject
to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as
defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the effective date of the registration statement on Form S-1 (File No. 333-261648), including any related prospectus
or prospectuses, for the registration of the Company&rsquo;s common stock, par value $0.0001 per share, pre-funded warrants, warrants,
shares of common stock underlying pre-funded warrants and warrants, Warrants and the Warrant Shares under the Securities Act, that the
Company has filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Nasdaq Capital Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if Common Stock
is not then listed or quoted for trading on the OTCQB or OTCQX and if prices for Common Stock are then reported in the &ldquo;Pink Sheets&rdquo;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of the Common Stock as determined
by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly
executed facsimile copy (or e-mail attachment) of the Notice of Exercise Form annexed hereto. Within two (2) Trading Days following the
date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice
of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt
of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of the Common Stock under this Warrant shall be <B>$_______</B><SUP>1</SUP>, subject
to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier&rsquo;s
check, at the election of the Holder this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless
exercise&rdquo; in which the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day
immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading
hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular
trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise
if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section
2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>125% of the public offering price per share of common stock in the offering.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a &ldquo;cashless exercise,&rdquo; the parties acknowledge and agree that in accordance with Section
3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the
holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to
take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
its transfer agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share Delivery Date (as
defined below), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of
the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the delivery to the Company of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). If the Warrant Shares can be delivered via DWAC, the transfer
agent shall have received from the Company, at the expense of the Company, any legal opinions or other documentation required by it to
deliver such Warrant Shares without legend (subject to receipt by the Company of reasonable back up documentation from the Holder, including
with respect to affiliate status) and, if applicable and requested by the Company prior to the Warrant Share Delivery Date, the transfer
agent shall have received from the Holder a confirmation of sale of the Warrant Shares (provided the requirement of the Holder to provide
a confirmation as to the sale of Warrant Shares shall not be applicable to the issuance of unlegended Warrant Shares upon a cashless
exercise of this Warrant if the Warrant Shares are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be
deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder
of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise
Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior
to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the second Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in
cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the
Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading
Day after such liquidated damages begin to accrue) for each Trading Day after the second Trading Day following such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; <U>provided</U>, <U>however</U>,
that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise notice concurrently
with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder&rsquo;s
right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such
restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise on
or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market
transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to
pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to
pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii.
<U>Signature</U>. This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the Holder
in order to exercise this Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise this Warrant.
No additional legal opinion, other information or instructions shall be required of the Holder to exercise this Warrant. The Company
shall honor exercises of this Warrant and shall deliver Warrant Shares underlying this Warrant in accordance with the terms, conditions
and time periods set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates), would beneficially own in excess of the
Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially
owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon
(i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in
the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company&rsquo;s
transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company
shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares
of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.99% of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st
</SUP>day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder
of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price
of this Warrant will not be adjusted in the event that the Company or any Subsidiary thereof, as applicable, sells or grants any option
to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise
Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other
than cash dividends) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable by holders of Common Stock as a result of such Fundamental
Transaction for each share of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor
Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be mailed a notice to the Holder at its last address as it shall appear
upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified,
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to provide such notice or any defect
therein shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice
provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Pursuant to FINRA Rule 5110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant
shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call
transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately
following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the
transfer of any security:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
by operation of law or by reason of reorganization of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
to any FINRA member firm participating in the offering and the officers or partners thereof, if all securities so transferred remain
subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
if the aggregate amount of securities of the Company held by the Holder or related person do not exceed 1% of the securities being offered;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages
or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in the
fund; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a)
for the remainder of the time period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the foregoing restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant
full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5.</U> &nbsp;<U>Registration Rights.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.1</U>.
&nbsp;<U>Demand Registration.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1
Grant of Right. The Company, upon written demand (a &ldquo;Demand Notice&rdquo;) of the Holder(s) of at least 51% of the Warrants and/or
the underlying Warrant Shares, agrees to register, on one occasion, all or any portion of the Warrant Shares underlying the Warrants
(collectively, the &ldquo;Registrable Securities&rdquo;). On such occasion, the Company will file a registration statement with the Commission
covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its reasonable best efforts to have
the registration statement declared effective promptly thereafter, subject to compliance with review by the Commission; provided, however,
that the Company shall not be required to comply with a Demand Notice if the Company has filed a registration statement with respect
to which the Holder is entitled to piggyback registration rights pursuant to Section 5.2 hereof and either: (i) the Holder has elected
to participate in the offering covered by such registration statement or (ii) if such registration statement relates to an underwritten
primary offering of securities of the Company, until the offering covered by such registration statement has been withdrawn or until
thirty (30) days after such offering is consummated. The demand for registration may be made at any time beginning on the Initial Exercise
Date and expiring on the fifth anniversary of the Effective Date. The Company covenants and agrees to give written notice of its receipt
of any Demand Notice by any Holder(s) to all other registered Holders of the Warrants and/or the Registrable Securities within ten (10)
days after the date of the receipt of any such Demand Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2
Terms. The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section 5.1.1,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. The Company agrees to use its reasonable best efforts to cause the filing
required herein to become effective promptly and to qualify or register the Registrable Securities in such States as are reasonably requested
by the Holder(s); provided, however, that in no event shall the Company be required to register the Registrable Securities in a State
in which such registration would cause: (i) the Company to be obligated to register or license to do business in such State or submit
to general service of process in such State, or (ii) the principal shareholders of the Company to be obligated to escrow their shares
of capital stock of the Company. The Company shall cause any registration statement filed pursuant to the demand right granted under
Section 5.1.1 to remain effective for a period of at least twelve (12) consecutive months after the date that the Holders of the Registrable
Securities covered by such registration statement are first given the opportunity to sell all of such securities. The Holders shall only
use the prospectuses provided by the Company to sell the Warrant Shares covered by such registration statement, and will immediately
cease to use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no longer be used due
to a material misstatement or omission. Notwithstanding the provisions of this Section 5.1.2, the Holder shall be entitled to a demand
registration under this Section 5.1.2 on only one (1) occasion and such demand registration right shall terminate on the fifth anniversary
of the date of the Underwriting Agreement (as defined below) in accordance with FINRA Rule 5110(g)(8)(C).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.2
</U>&nbsp;<U>&ldquo;Piggy-Back&rdquo; Registration.</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1
Grant of Right. In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have the right, for
a period of no more than two (2) years from the Initial Exercise Date in accordance with FINRA Rule 5110(g)(8)(D), to include the Registrable
Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated
by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however, that if, solely
in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall,
in its reasonable discretion, impose a limitation on the number of Warrant Shares which may be included in the Registration Statement
because, in such underwriter(s)&rsquo; judgment, marketing or other factors dictate such limitation is necessary to facilitate public
distribution, then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable
Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of
Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number
of Registrable Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any Registrable
Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such
securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2
Terms. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 5.2.1 hereof,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish
the then Holders of outstanding Registrable Securities with not less than thirty (30) days&rsquo; written notice prior to the proposed
date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement
filed by the Company during the two (2) year period following the Initial Exercise Date until such time as all of the Registrable Securities
have been sold by the Holder. The holders of the Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for
herein by giving written notice within ten (10) days of the receipt of the Company&rsquo;s notice of its intention to file a registration
statement. Except as otherwise provided in this Warrant, there shall be no limit on the number of times the Holder may request registration
under this Section 5.2.2; provided, however, that such registration rights shall terminate on the second anniversary of the Initial Exercise
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>5.3</U>
&nbsp;<U>General Terms</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1
Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement
hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a)
of the Exchange Act against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses
reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under
the Securities Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the
same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section 5.1 of the
underwriting agreement, dated [ ], 2022, by and between the Company and ThinkEquity LLC, as representative of the underwriters set forth
therein (the &ldquo;Underwriting Agreement&rdquo;). The Holder(s) of the Registrable Securities to be sold pursuant to such registration
statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, against all loss, claim, damage,
expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing
or defending against any claim whatsoever) to which they may become subject under the Securities Act, the Exchange Act or otherwise,
arising from information furnished by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion
in such registration statement to the same extent and with the same effect as the provisions contained in Section 5.2 of the Underwriting
Agreement pursuant to which the Underwriters have agreed to indemnify the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2
Exercise of Warrants. Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants prior
to or after the initial filing of any registration statement or the effectiveness thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.3
Documents Delivered to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each
underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel
to the Company, dated the effective date of such registration statement (and, if such registration includes an underwritten public offering,
an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii) a &ldquo;cold comfort&rdquo; letter
dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, a letter
dated the date of the closing under the underwriting agreement) signed by the independent registered public accounting firm which has
issued a report on the Company&rsquo;s financial statements included in such registration statement, in each case covering substantially
the same matters with respect to such registration statement (and the prospectus included therein) and, in the case of such accountants&rsquo;
letter, with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer&rsquo;s
counsel and in accountants&rsquo; letters delivered to underwriters in underwritten public offerings of securities. The Company shall
also deliver promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to
the managing underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all
memoranda relating to discussions with the Commission or its staff with respect to the registration statement and permit each Holder
and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the
registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation
shall include access to books, records and properties and opportunities to discuss the business of the Company with its officers and
independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.4
Underwriting Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by
any Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably
satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such
managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily
contained in agreements of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating
to an underwritten sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties
and covenants of the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such
Holders shall not be required to make any representations or warranties to or agreements with the Company or the underwriters except
as they may relate to such Holders, their Warrant Shares and their intended methods of distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.5
Documents to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company
a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.6
Damages. Should the registration or the effectiveness thereof required by Sections 5.1 and 5.2 hereof be delayed by the Company or the
Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available
to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened
breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and without the necessity
of posting bond or other security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and
in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company
will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or
stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, or
otherwise able to be resold or transferred without restriction pursuant to an exemption from registration under the Securities Act, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CEA
    InDUSTRIES INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TO:
CEA INDUSTRIES Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">_________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. If the Warrant is being exercised via cash exercise, the undersigned is an &ldquo;accredited investor&rdquo;
as defined in Regulation D promulgated under the Securities Act of 1933, as amended</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing warrant, execute<BR>
this form and supply required information.<BR>
Do not use this form to exercise the warrant.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________
whose address is</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
______________, _______</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address: _____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement
or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper
evidence of authority to assign the foregoing Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>srna-20210930.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaODqbP9z5Z8eekhvWB8benKHyQkWr8tMitcYA5W0XcK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:SRNA="http://surna.com/20210930" elementFormDefault="qualified" targetNamespace="http://surna.com/20210930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://surna.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>srna-20210930_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>srna-20210930_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/Cover" xlink:href="srna-20210930.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139681495012232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">AMENDMENT
NO. 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CEA
Industries Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001482541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3911608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">385
South Pierce Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite C<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">993-5271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>forms-1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="srna-20210930.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-09-30">0001482541</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-09-30">true</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-01-01to2021-09-30">S-1/A</dei:DocumentType>
    <dei:AmendmentDescription contextRef="From2021-01-01to2021-09-30">AMENDMENT
NO. 2</dei:AmendmentDescription>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-09-30">CEA Industries Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-09-30">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-09-30">27-3911608</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-09-30">385 South Pierce Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-09-30">Suite C</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-09-30">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-09-30">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-09-30">80027</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-09-30">(303)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-09-30">993-5271</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-09-30">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M2HOT8 P$*>/ED[P?)N+$ )\SP <#7'"7'RHH'X@FHX$4>R1-;U SA6*HA37
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ 9X=$5 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !GAT14
M-T;TSNX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " !GAT14F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &>'1%2_3U!NRP,
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M2P$"% ,4    " !GAT14)!Z;HJT   #X 0  &@              @ $S$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !GAT1499!Y
MDAD!  #/ P  $P              @ $8$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  !B$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>123</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" original="forms-1a.htm">forms-1a.htm</File>
    <File>ex1-1.htm</File>
    <File>ex4-3.htm</File>
    <File>srna-20210930.xsd</File>
    <File>srna-20210930_lab.xml</File>
    <File>srna-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "forms-1a.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "forms-1a.htm"
     ]
    },
    "labelLink": {
     "local": [
      "srna-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "srna-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "srna-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 123,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SRNA",
   "nsuri": "http://surna.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AmendmentDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://surna.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AmendmentDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001493152-22-003277-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-003277-xbrl.zip
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MRZ-F>.?%IPF8C5=TGV*-FCR(_+5#22U11EEQE86C*W<??(I)@4;34S]4[#5
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M/F>(NG($.L)@ 0-PUV8X8Q*?$D*M=02+H"! 'E>,0I6V*IP.8!E-?)&$MLP
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ME4K:DE:COSOHE/I[*Q^=5$RGA^,HHTU3S9*D]I8(K%W,O+P2'6,XL+[8RDW
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M-F#HOE\X6 167Z7LN]G^AL[YBQ3"H$L?O(UD\TKN?8::V*64?Q;J8DO7,)M
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M(R:$*W3R:)G8,$7I)(CQ<M'E: >*LUHJ"LG03SKJ9E*<X6E6N&60DT2""2G
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MD:)2O<B8%).L97\O GC).V@A1'YM3N,K-3!?<9%SPG)>Y(UESL'DQIBKPF5
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MAE!/8H[<Z.%@VU8'7]!H\H9X57*DV+L$+:$55%>9W/98KD9NH&MT\!>6DHS
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MSMXXT;Q0P_]"0^:W'\UCZ<1^ ^Y8UV$#GDH<A7V:EW4!&MWE NS][DJ#$@5
M@FI#?FF,9T5Y4,HO9TJ[ "VR*&S(4_R1]G?.]S"V>+OV'I43(\?&DMZ&B!%J
M=D7-KK#9Z@6J9E')F9!8V(-D %[3W!#HT#TX&<DVP'N& RKV0Z($?IPM\[B4
MC.=I.JU7</GCXQ$')OEKU]R3U]:2[.XF]'2,L<+#]AMOQ[H.&X]Y&_[G78)9
MQDG\O[S?=G(T=GLA<([J>\9D'X+ ./PM(O8H%%S+7$%8W?*8L,94<(@C?E?1
ME13]@@LV/C,4=SO66AP.-EYNHZ3*=(CN<&85%J5+])7(U'^C6\B+G;K:B<UH
M0FJ,M%YR4GDP7J[(R;0.G?+HT;F3>-OPVY/[RSS1>2-25R1QRC71$ Z)[JLU
MKWE\?*(I;AVOL36(!&W'<4:B\C)#VC4F5!$39PDG:>.(-XC@B".NG#O:9N/I
M-FYIF\6)77CR$2-U,HLR/&8-91]V^K8-T:7G0O#Q^]]D76Q>2MXH8:0#"Z"S
MBHU6[626Q#@+IX?/<>$'RBH@9VG[^=0V^X(&S0"Y)KFDFUVZSN6\3!=%S?Q[
MS@IQB V)4T @ZH5)'PX>'\0=0"E*]C;MW79<VLW>=(?),8RZ>[9V*V'XJV^)
M[W62'>LZ'$6<N_0"R03* E80O"**@\M9<=-]^C!0AF.$:+\&SQ!E^!)1AET/
MZ<IFXG5X=@:;Z.#)B$2JUA3HC\A*4!=7?EXX'BTG@[C$ER(Y4E?ZNPG_PGMG
MVZ <)2=>L-<=?#]XOQ83VN^<'>LZ[!R&(?^-VNPLI/:VH<(CN:$OX%XJ(L[)
M]X_TD.] +IB%&7QH%JL<#GZA1 @G-O>2B98"L32"2ZI=[)FFS4OH:3;!C8!7
M#DNI5L3"SZ:"EM0O)P)23"V@$*$B]O13:**,!O,PQ3\G($V4 #PJRY4FN_C#
MTWT[[,CE1&XND7Q%;W;#H*:X &+CRA0>2G!!0X& ]6JY&8EI1%<+-%!J\]RT
M)?S\.:X,R9MWHJ?&&\%JBG%',#+"A>[IE.AC66DUU!*MLYPFP5D1[T-<%&7P
M__JFG^86B]COXD[=;2'U0V=JLJ:CNCG* D#%#(3U92?6U_UI$0)I G/(^$]3
M?T*X^F/F-+39R]TL<<HIB$1Q04;9ES;?=\+["[X>F>QH)S4Z] !,**B2";,L
MA@&6OY!TJ!@K*7%B=9R4+O-8EER1Z' J7OB8*+\2.5TNZ*DU6<9[G6%;X,*3
M/7#ACH$+/SP,X,(N[(W=Z#H<50PL?I%?IV!#2E9O)X>&"=AN=?(HU1]2V6XX
M9$(.Q[K'S!;G26".$SXR^/1@.+.EI 4%NK;LJ[,EC![FR6?41#!;HVE2RP&;
MV"$("7LWB_X%QTNQ9$+9XA-,/R:"U)); PHN42$L0" MX<N:R4&HG@$R<.$)
MY1$&!HX=T!YO:P3066U9 )1EH(>@1"@6PAZJ!B?)W\]61M5:21RLP<V:QUQ3
M$!QRDW:+<8RU6F$+<#@V!VX8> I(,_%=G E:(*%T?(.& 4V-$:[$Z.77XW*(
MM4H</\JRFA"\G;,GINNGD_R5FR=4EFKM8E G!5=7=;GD,)NEF*2D>M!,=8R>
M@KS]!;N.\'<G1=16TOF6?=ZJQW?>VV;/SH[$2N 20TV(;UL 3\R5)!.PZ Q1
M%4QAP18WU4]W.TC!,?\79_X_8\!V^* ^.V+\UKG#FE/T0*_:"Z?"VGQP8&;(
M9:Z2Q@]HA;:. 'MYPT;BO,<.8;BN>O+NX6('UM5([A3 BF39)\$+D_U_$0EQ
M!1X4>)E-@EO7$)MGV0C2<;\=?%@Q_AV3=2QU_1X'L&M=/SMB()9ZZYQ8A%%[
M=W)@OL9!NUV?3[Y"CSNF_>CDJ.&6:TE*HMOY79AT->R,MYZ&(DQ(!5_94)3G
MD#+1WK/C\\VQ+G'-D3L?E>'IJDN&(<'?@ASZS.A#N 2Z4!1H*\RXYL;-+,DW
M4*NT9?=P8(4W=W2<$*6ZO5]\\3V"6!_JB'U^CJW[07+_:2"11QD]*BAA2Z7-
MI=2 6P!#2(?H3KZ54;^4H.UD7<EU)FJPML/^8;7-4>?T3$,3ID2#6[,0VWEM
M>HCH13+8VNW47/BZ6+#YJE1=ZM&\%=6-]*)WT@O#V,[O6I3$62[AG,:;EY4Q
MS-XB$F/..7%V",A ;I(*\"LH"D./<S+>?2;C]50V_@8P(&SGJFEA.7BH)<AT
MJ5@LMW2RVZ8TAYN-W:A%<IUXMJ5JLP5?#0<%!XDJ9QB33Y$AVH:?<9IYL:C<
M>$)PE1+^3?HBW["=P5@W% -K6(P.8$FE/D:7=V@E \YB"]OF=$1Q5:9)?6)I
M0Z#]"R<,2]&VU%$E440&"M(X'3<$MYIEZ2E6#-A"FFK^(AP1.=$GQ&X0#Y-R
MJ+QF6L0>MYO[$J)J*I:UASYR+CAX,I(@+7>!"/<8T%PG"[+%4BR9B50Q%K6-
ML+ *?3)8YE+%.89)DUH)-JCN, 9HK8RAY'UAPL/5*-B+]LC<N P<SI5M@4.4
MYC(>M/DI\#T<0)MO&&868OOI0-)VLAJN/"R:V-EA7:#(8-@;"&686R2^HV!O
MJ:]RA&%+],%9J *)]Z<C0;C9#GLF"S DC21H.-&T,YT@!X+2:>T4,FLQ?2$=
M!U%>S0O<7INTO7NK\GQ.S.?'?<SGCF,^3^YYS.=A+?\'TSLR2M2>4:*A=867
MNLT7_SP--YZQK:Q2"0H-!WVYIEA5(^*3@"(5PHU$+*6.*NA2G:_1-KA>--84
MB6JE+("#X-P4=U>:@N3P)5=Z^8UX;^K@N<=?C1?I+^9F31^\?59CDP1A.'!8
M$()7= 916A6F!K.!YI[US2! N^/0QP,L#8VD-XK,8@X'.B'QN(T=?>;DA]-M
MP)U*I:WWV!@45R49)R-/5^IXG#+.D&NQ$[$Y'%"QP-Y)94<C*PF\2+GV$8=>
MV,)2E?%36M7,C,=EZFVYII2@V4;I,GI.L0"]GY;4<-"PK)\7R[Q*,GX1_ZE#
M:Y$W!2=]H!FU3D5/<]%*G'R!S@M1N6)V',FG13;.95Z7R\36WV,UWK#432-.
MMRAH^Q1\7>N"9H'XFEGPN0@KL<>[&ND<5%<IK6ZK_NG%V#Q0&K,D$N+JU(Q!
MP^A?OQM:-F+'.,GMP\$V]X>,UDR8"7$>H1$4&@^*,Z2KSQQ39'%UK[!C9EO.
M@Q=L-7:!T4D1K2A;8)*6D^5<(X^TJ E):8EN22<G+*KN*S0B#'"RE,I,VZQ,
MY8C^G)ESQ5CWT+NCLLDUUB$]BLZ4G^:)8[-A?-,$:WI<4:I/VVUFH\MD,I!X
MX:H,<-F"TI36.+,(<4^T7^ZF00(&)M06F\\9X\)X=?P5\IGG2'OG.*.+-(;$
M+NZ,+QE)D8UUH.M'JY[1J6/".^+JX(B,(OI+9CJ=+LL\K3IC*32M$Q"GB58]
ME6;TCB%Z+9Z/V( TB\(S1]?'=IYR86:JYM7,^>?S0,-$Y -2(/#:1JV+%A5E
M\QL](7KB2+Z"Q9+=C&"[)#*W+%]J]40[F.O'L6H_"1>GTQSQA7KMX:K<7%YX
M[?[ MJL#AM),U)FE?? T.UF8O=J>N%P>/0EF2*"%9KU3GMPAT4>EMTM#W;RA
MT<M 50^TT %M-C/ULJ2-!_G< ;'@2ZG@2L92.:H3XQ]\#EN0=J,&(5G'2DHL
M-6S(4C%C_=,B];/F?P49#29!5M0T8[^R5D:D@Y)Y:3QP)QA^4L>$>O^WWW8L
M5X650VH*'"!OXC8[W[#I%E0MW<1Y.^2Z&YC@'=S<8?KV.]I2L(5E3SU4B^WA
MVZ,":&G*!G/^L5'ZH;W]4,5&AWP2')R-@E42(0[<X -B8;3P+3V;&,S[U.S)
M6 DNN@U!=EF;#P>%\Q)3O6/;NVUP2P4%NRK9UUB.0K_:O.\I=79LTVFJ)5%D
MOSLJ1#/-Q2?=4+%E&FAR3GT#O4OP4I9QPB^3D;_U6_QS0;WI]4R%D"3.HB*U
M)IU]MSRR#Z9W* (>L0AXB7OY-XY*.TIL5YJ>P-APZV$MM R9-)%<AOSY57OM
MK&="H  &K6<VLHUJP+4X-CM:2 1(3=9"Z W(1N=J)T%/SU@O,K>: @*\TO4I
MBOXE"G\)VCM^H-"INPO&'K*^,8L.5_-H&/@,HVJ0CG;IV<A[CE6PN^KJNN&D
ML[,NC;L34D4N'T3>FE)X,BO\#7'ZR(#]DN2$L_F @]$W>K!D; T)E#.6E>"9
MPTI@Z*&;J<?!AMQ\/ZN/A7(K1=^F1H\"GYN^3*[3Y,:.7D-<>>O9,(EI46)^
M3DWA9K+"G17/L3?4L^AW'CC68KN7B#?.(7.DT3SXWTL[/9LA\@J_\.2X;T%5
MO;42NU.YM?JZ[1XCTX6FB3K4] 8X60 ]F)DS,6Y-,6LMU6-3SE"?S=1<Z5SL
M-P3-UJT28E:8X!JP95Q=*_B8) L"_S4\LPRD);>-1"JYO,;&W4]-=4N[\]\T
MXNS9I)DR-4"[?9@T\>O?1/)D"@,I:\E(*OK.CHB#1V$ NT[A>D^1X?@SCU[C
MI>2QZ7:I><U;[[>\M8LM])QJ1M5;YU6+:K>0&<YUV'#4-8@X/3^3 \[R=Y2N
M=1O4[W"U4:DIU/>*FUSYIL-MYIHD*6-OF*30\S[IG(==\V+]47M=ZE[V#G6I
MQT>WX:OJ%65=T;7;, CQMH-%=1?2;>N7]DHB!$W>QKG_5241)B3=SK]_6TG$
M^E:7*/*5$,:2-JZ^G33:?D&LD4N(.&O.S:Y*H_58F]/C/=;FCK$V/^ZQ-O]!
MRW\WTB;.CIA?]()#M:O.R \SQW0HW1T.D>6BR VZ?8O,K0X(+@9,R<T>&A_<
M9 9#BI(>!I',13>BT(<[]AA\)&T+R\1%7KA*[#27&B3Y-$O'*0'YZ2ZZ!)O"
M%9Y:C6!H4EYI*+.1PCREDZJ4_%O6N:.L*IH#XXYYJ^MP0I+2#//&[U[=<??U
M?=KY46#YC:?M]I&]S<Z6=&IU>M,\S:ZWK&_0NA<7OYR_D_,ZUA7GV-/H ZF@
M(Q7&G7A=;3/5K#WT=$RB4^S::2UM9:-*<2,2@;Q<E1A>.AH_%\\L31+/E@PM
M&_\-<]Z-14K?I72-ON43!@(%6R95I1R2ILO#]_MLKAWK^MG1HZTD\GJ_]"QR
MX3>PD1L4C&A3I(YLIBL^NE<@8(2VE//BMD FJ GE/NDVI7NZTVX"+;/G/+(#
M"(".+PW26#@ =&2\LF)61D52?43^+#2]QB2\>#NK#=9I8R "!P+1ZCZ3I+K]
MCY>E6JF2G?'U\9'#P<D/IYT@QR:<L8^S->P'<S1P.\B&23(U:5AB23P"L=LQ
MG^O '>Y2:-8VK_SG5[<0X,/!74GPIC_VU@(<FK*7X#LOP84?UTV I 7_XII6
M]CO:KR@1WC LJ%,S[@/!;Q& 9UY)BIOW:(=P$:A<&*.WV99,RA.0GPS7M!L@
M*(OEU4P0YB:<T48NK($>L)+VK9 +3IK;&J=3.F?ZG42*[ZS-3_Z)@![20B^Y
M=9,FWA1U*MH8FFQ" +=*MNW*# T5W^:DAX;M_% Y8F#(Y9B4W.3.AO!K<9(L
M]RQ%)_V6-;-/R>/XF6FT7%FE,,F;_0FR=SX*-O,9]D9&846N-._K8HUT;9]8
M>D.*^3:<(T\I8=;/,I=8GDTS9_XE-K1-TGAG3G?0F8_.>;EV2<^BQ<++*&;G
M>$O#02I,K[9[6CED X\%"R&>9:7*;)&"HK99V=75YP8GM?4+2WNVT<CBY-4%
M(/I3)1/_T1D#Q@,1\O\@&JVU03\/8D^K%1-AI9.?F8]@7SD<],0<USCY64\T
M.$C0A!.I#-9T[U.DIH70Z)025/!/KY$,&/25PAS[<DRR]UF5]$6$$Q/J"BQ0
MGQ/Q(IC3D ]"FU9+K@H.*7"P@Q-LU6R@=NR5M!WK^MG1]UK1+(6GPV)X2>76
M4?)8_^81P7=>,J*)[3NR%T#[.'B\+=8S]"6?1+ T>@7[E7,;(ZO8H?E0$G>P
MUNF)$]PB*"05XDC%W^GDC":8 $9KFK670B _(%>DRGP$&EL]<MMA> ZFVFU/
M<#1]?XQOG8)0@O&!/5J2\>7J3PL\IXQ>&.4YM&EBY3KL6;F-O)$ZU,XIM=^"
M.];ULR,F&G_-$>8OL'<\P'$F >O;88V'@P/?LFFII2,M"FA0PAVI&%^,!1\.
MMC>IOC86''0::U+MM^>VD?&3?63\;B/CI\?W/#*^0WMC-[I^=L3$XU9GE.."
M*C90*N%+4,7X2/N-DPJ_/P8=+P,M+BI!1J^J7@[1+DM'6+4%"1NY6IMH@:5Y
M,RF!;EGI"7JL):C3%X+W5%2V!.DY!C%/,>P4]QW7C02[CL]9!F-79 "S%R93
MS51].)PFZM-N\6F=ED[#U0,/7YHZ.K,BBRD>;AUZ/ R:+HG44VB ,DTX?D8,
M]O:=GS:4>U27*8V#:P[>%,'!:?LD]V=L?S;N6-?/CGX4ZW&A.FB/ W\GA^>A
MHYM_5#+6MR0V2.[30@B#I)ZPU&\Z#6YK%72= AJ;;D7K'49K3[@UDO2MW>V8
M^K9DT4)[0[(6\[\CE+:\Q"7/6AO$+F7$:N.;";,M<5HX":XX:RHCA[E(<.-1
MS2*.F%#U=?],(%24Y>[SR0C\KG$T)C)(*')6F YPH[O25\>)%R[OI7?H20K5
MH[*/04#99FR[T#M)](!59>HY$%R)W)9Y<H,)@\F<^X_ZMC;()!)UEE:(IM,H
MQ?BW*5<G#V\FR2GQ+#>)H@@T5B^1M/')X5^5441+U[?3\B0PTAAK+Z_7^O [
M\_JZ< A4^%:C$",AD;#A"TW05V7!!C/6#8Y.CXZ.$D0L:W2D5V[I%S:,+3F+
MK._&!D(T0WNIM_$-7NYA3]HAX@8I2FEP+HUQ(I"? QYX>6%JIM0<FR2, ]<)
MBXS[0"BDJEOK?#WD!BEG.+?H5'N(4AT69)I$UZ477)AIW YD@4N;@!9!1>4G
ME63:GW+:,+C10LP-J1(&\^-U<9*9*!TKH6%OTB=Y.SR.HHYQ\KAQ&[$N/ 8>
MZB'W\(]PX1]\C[@@S*X^AU,+KC>?+V=)H@CGK\SZ,!S\FSU]&UD?Q.:*&$:%
MPQ-=:8?T)"@W2QVWF*P_\$K>9^V\%AM14X)YG$I&'%5%EE!5(SYE.<HBA:#U
MC15-;2,F;9_@,C;R8'2<"NTS(&Q@8V)0SOA(FL,:G&6,7D1G'G/;=;?&'Q:Z
M_>+]\R,\J##&DU ))O9AFTO_%,T7N')A/YEYPW3R3=.!.>D3@HHWWFH@' WG
M.1+M=WG/][PW][-W* ?/C!RDE2N6#,N]"P9_\.Y!S4>TI YNTY(C+X@3]<,D
M/1F!J"SU%/.!0[][;_L9?VJ9T#E/ %%1IXQR[B)O%R4A[:27:^@\N_1 #=)V
M %L?ZM+XG,C'Z3[R<<>1CY-['OEX6,M_-[QW9T<GQ^S=BE:*WWC!DI>.A9T<
ME(>N!YP<JT]3*8]TR@.M0BZ'M595Z4@ZXAP=90B",Q?T9- &7"!1)T^E4$[*
M;\,!1\&X:$;82+7 ^,PB2F.C_SL/# /FV9:&@SI.'A/C$$A*<DU(#0_\JH#S
M_TK"3[XYH,5GFEY9H^-SN@Z%B])YR@/T$Z%$;5&88)J(:],C=+)-;.8&=;#E
M#0<=/%],DEUDAA7'U+IIP%AD:%T82X</YBE!4+'=\B[SN)?<CTOQQGC=:E2)
MY?8KG,YK%*R*EZ_>O#N']TQD?'1@>H?"P?&0NM>!$V\"<B)%D;(_NR);)?FD
M(-Z&"UM77\LHNN+2-G%28UI/CLCPV+8ZM$TF;'A:C9=EE4CI+[<78]!DKLIB
MB=,_2R8?>RW.8CH%Y;34!R(=15%6C'A7/E1<:)B3]@GQZ\%_G3P.CX^/=?:C
M*UB@L(ZQJ0DF9FW1U@UKK]RVZ)5U[HIA/\Z00./C2DQZT)WMQ9G4#K84U&X
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MR#F][E8W\B"9( 4S\ETS1EH)TDP/%C!2)1;B<N,<D52.J1;Z?IY6:1"YZ.#
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M"?"PYX'DRVHB[\MR22@A!P9FE%BA1#>K.+-)W+7T@]P@85]B=2J^ 2&U@T[
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M%@I(0Q191<O*N;?M'<,W@4D0-_$>(F!'B@X?OV<N?+[29MF'5/8!$>)D>&&
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M<PY)%V1>B8#MW*&MF"571G\7GIFI89Z)36G4\XQ(="2!"],>BWP*"T5'E-H
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M2RPA"WOE)!_#?97 EKY,)E@5M5P44O0RZ(T ,=Q.X![ 69']5)'  /6^W\,
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M!WP72>8JX?CK.W,5K \9?+.-#GR-Z,#!-CIPMW6@CT,T'!A$@Z(^Z(/'!B8
MC<R@7D2B*[2FWZ.-2[H+(_M5[7. -.(TF2>3E !85Q<%.T'@[^B0"_!>)?U9
MN< O>F<KPHMD>9&3GT688?#9$$.%?9JDLPS$RBJX%^BZ)6V$+[1B.B7=T-RT
M 5()[J^,QS1)$4$GK8.F06H/CD\X3>0]'%1(,4BM5Q;YW1$14V)47EZ@7RX6
MH @Y6LFH*#Y402^&Y B,)LL9ANW3\9(TFF1,2@,B[!9PK^+ TITY*,+PQCH9
M7Z#?<:@MO:8.X[_,A%)D)<ES:'$BA3]WH]_@RD7%YJJ(!@=#5_L,86T:OK&
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MYU2HF](Y!22RF%W"/5\5!S.$)@2Y$)S F)X]=DW4!(/' @^)^HM$K*O,%J@
MB45[Z]'UYM_QM>>S?:N=L90Y+?P&+CE-D $E_"FQ3;YB#Y+'Z2E0D.!E<7!_
M!E\WD['&-L]<7CL)$L QY9R<A1U:1>#-YE:L5D#1\+3N3B #G5OP%=CG<J*[
MR_4)N0JS7@0^?2S\OM]S 1H;N!Z';=J6\>H7FOR?Z+Y 2F(P77)SY9]SN,#Z
M8DNZ!FB'M*].P?R:>:$\/U[#<7M,H7UK=@7@3,*-C9RP.1/TV'0WZNBM):V-
M(TG]:<6[M82V;<:W$IB3/L)XNY9W">Z(JZFK<B#[C_WJ&M2\-K(<'C"/%=?3
MPOR^M7;+,F[2<(ESM07F8F:P.RB:Z.#"R19FK>!50YO^M;Y+1K6F(XH^ZE&Z
MHLVH2R[SX'!>H@2F;<A+"KW+:LO?)'D#O"(,@_G45;D[19JO<<,>;-VP7\,-
M^VSKAGV FB476WD+.M8[U+%>NLX]R6AZR?5J;5EO0G5T>ACCL%*&)K:@52J5
M(J1ZD;&J!TZ:*>6"ZS=8S[=4 )IG>(N[$;2^%&]!3]-4;CO[  7QKKV78\_1
M1F1]:$V+(ZOP0HJ;8$_##MLT_Q 0%EM]%[]=L$9E>Y.8&0%M>8'I3]-IW'#0
MQ3:!$Y416IYSB@+&!$CDW%WG8Z<KDN'I<)T-?2(P=VOXZK)K,Y"C@Z''?L$2
M%[J!U[_%I@E",T#+FSO3HQUHT0;<?EGV_7D+AM*C-B!MVFG/,LW?3+..;J98
M-_UNMZ591S=5K/N]M9KU=*UFW9CZCU>;D0OR$_1FHT/9Q1341W-[##;(F/\4
MW=F2@WJO_0C%&4S[C]><-STJH=HL76L'B8NA?0/M><WKAA;'8K' S1]U*L[6
M6.+.AB4ZKE.DHUO6H]TLF&& XM9-Y.)ZA,1.:B[ #'!Z0&D$AE=$+F!^;CE[
MS*#&4VD@=)M-9;3)3'H"L7*Z=B=Q'%\K@>[5,I\D<^:".+,7J>A1)],;QFIC
MBM5Z83-F N&M@EQS_"^Z2XN<E2O&QS(TVKG-*W$F5VS?SU,*0C)<FRP@$Q)Q
M=3<"*-&[Z%IRD]$D!KI1]^35+$#(!S]#]%F,WJ Q\JS@N53VC]B09,0,&5VI
MWZ;AE2=UA@,&U7*$\R8G25A=' W1SE ">E<IV40R40(*EIG22*PS)'= L1,I
MX+!"K>SM4Y[25.'D_,E DRZ: &5_2O%*KHP(\(GF^+ITKLC&Q6CJR9"L39%V
M23OF= E>EQD*O&FK*HH:.$4WC$Z*PMI4Q$G&F)5D0^9.GP[W_F+VH.PD-X+I
MZ]H4;=YD^U"5N$VWMY2H"11C^*0HSY-<* :$*X,5>_-9&^J3@T2X),M9590K
MB:_;^6RN4:.1K+)Q(.(!U70W.E7.XDS6+$CDK$=,S%6##:=O(^& 4F YGW,F
MG\;L-59E]CN5H?4,AWYOM*P0KE!%;JSR6NLH6)"XL1QLY^S "6):M!;K9:B9
M,M(3/D0</<1\$7A:\V:O\*(?B6[F'CG[M!B-%4\2F:*TG9O;N M%8 $GG,S6
MK2VYN-ZP-W["+]C*Q U3DIJ @$H*D\+F+L89+2/^2U'O3AJ&UPP&UYOML#=T
MXZ6.VE8:C$0RXEQ+<<TU:(Q&,A%SB9ZPUFR"6]W)XPW%MZUB (7M.1N2NN;7
M(0B(>S%C2)A[K=7FDPC[_+).1:UBS"S_#KM8Q]#C=03*Q@)$0ZC=!,0C[$&2
MB_5\?\,-TZFE'Q:@BYN)SD&##:HH ]V =.JLED*HR/EUR1AXYU<VC=WA8B'\
M\R25=H.XW-$,[#H$GL!KG,?<O4/V(JPQES%<==^)+29)Q_K8S<*G(&S*DE&[
MLTRWM9OVU[I3UK[W6N-_@Y7W4P!;,NZ-4>I3-#:P,.L06,D"+Y\R"R!!FE5@
M8YT="QAY5= L6W'7X^9 ^I1^>(^U+Y':N,Y,]WO^$6Q-9X3NBP7:,GSHIQA]
MG?W,:9.9LIJ2>R#I=;:P#B6#@JRZQ,B%+LHD0_T011XJ&#"VW!;?Z7@AP3_7
M:8&(Y&>).KXH: RV)J55*2CER],IQ*]B2FG2P#K%6;L;8J2O-SZX1A\ZAH6%
MFO7=E;T4.L/101VYCGYVE[V6(R%2C_PF*XY]=AY5PS/O[B%)0K<"$%&4OD0[
M-:\YIM=X1:7Q_,!.GZ=N:A\ELJK>X7#!![:95.;>@ YJ35;5$Y0IG@XK68SF
M_J](_6;:,@IWDITU3NVN7]DZ%86M].OD*Y'PN&PD/!OAM\R=$S2!H[(:=LM/
M[U1;_-W:*[:K&A8SG+ BSVX09S(3/3"&0R5<RGY/:=@%EZJ3QTQBI#WY=JFZ
MV=MG-"RWP_LMN&0(],P)24@[P+IFVTW? .#23(9C8,<?<=23).*S,'3!V2H^
MKG-Y,U3=N9S7)[=MYOA>J^9LN$M8]FM% M,:0_+$R\VL"?[K^ &3Y&W>TS7'
M Z1UJ5G39H\)%ZQ7*I;P#E@SJXTRWEUB26\UT^BZ'L9R25^_70RR(9@,)K$Q
M+G?6,O#G<,)K>^-%6/JSF&=C=[">YM2E5!M#U'4*=PQ>2KB;8](ED;I.&Z\+
MRP(GD=O7ZXWVM.XR;!XKOFWHCB$]B;LZ2KD#64TDMCB/@ZJ0&!55KR9Y:<NG
M2RCF^@ZTR'@]:*",I&7I)(W+Y60RXYW<9%15IBES(::)2=(,AR<SCQF.9H.D
MQ/;*AAA^N2BNTM!H</#2<N^)IRZXZ\(T\+;+SEQO'.T3\K$*S9)V28>A/++V
MN+(TDQ.8-]PF#>+G!\$\V8)@O@8(YKLM".8!1F^F%+UY84FB%/IR1 :#_=@5
M0T:##KCM31T!O%AKVG-*1:*?[?\5S@4&5DP!!J5*B1RFE.LX99YLZ.3Q*(XD
MVXURE!R7)H?D$S'?Z-;Q$I60&+V0&D2WDD[5WH\[(WV__/O/AUPZ1#DU6"NY
MO3S8KSTIGU09D]*$;7HPJ6Z^JX;S'WZ[2//T4G2GP)<#)\>XK?R:DRNK/#7M
MXY9R)L0!M<! RSS)9@8R8BLL\R(VB85"[Y)-XG-JGZC'E#V7=#C=@0=GWN>)
M9@O,?W$2C4HLFD6E^;34 3:"VK'2TQE/BGW7EN1=ZX;;0WF$7B=GZX'1[YQ3
M=,T%5%H!^#%Q(8]N;K2'%"1/$RP6;F2T6XS3UXN?]GM(I+7N7514+4%T4%ZB
M)X-6V8-72I%5]&!.L+1?1Q@T)NZM%M_I$@SX$O0Z-J0H;T',#*8]-V[*1DQ4
M*XV7)@V(+=T1%D :L9>C*)UPE!=,:[@V3 H0)P=.;>8@1O-?2D%/<D,E,V/5
MN;F?@;W1I']O*<O9%FHVUV3 W$919 ]I42H((XP<JV<QX5A=;& 37C&<:Z /
M-&""/C0IM1I1[2@(:FNXM"V4'8:O-XI61X/CH5\+-=A![,,H9DNP;DN)8-M_
MPO& F1.LTRR#%;&3>)6Q"L,!7QKV=)IDC26UL--^SV2=MTEW]A"SNH0"'M64
M@.Q*13U7M8+UKS' 56)LE/!E-K8 &I_-$%-A_2X]1P*@LKDR6$8QQ>8.]E#Q
MA",*OY\@6X/G)'&2S 0[B5YL/[.8[5FY8[B\(B8)X35 Y6NEX"X^"_UHS:-B
M4DPOF\KQ^'B)T;$GPF)'H,0M9YVV1#;UW@8S3%>IOG)-GM4ZP4*@'FJ3VW(Q
MD6MZ7'E=ECP;7SZU@D]Q:Z_L3-J$-,7 !C@43P;$(@$T,=F>;0G'8^4D.9+D
M!5XP92/U(L@V1R07%H>Q<:[&U&6UWPKZG#::2H>UP)W.=DQ16TN$&&X1$4&J
MISCI@T!\*\K])K-H.OJ#H8^+#+#7*1.J]5U=QC(1E<SAA3^PE53!$BJ02%Z_
M05=G-G'"!1:++[[:@ K8G$I; (Q>VHH?Q5Y(G\P@C&>:9X2]BGRXA*"K0CX^
MV*QP-1 !^(Y0;;J53]C]KH[;(+O?1#XDR=\P"_LRL\J0HB/)TV)9(2D><H)Z
M\]A"#^IKX=$+\KFB<"164?B>JH ]V_F'6XO79Y/P=V-+-99^;\+9*R2[B,*4
M*H6G^9C@,'G3R^I+^D"HRG1(*340$N>IU9WEEZEA[48[WDD9P>/S![)55^B@
M_BSU5[ZZNOUQ7%!/#1?4F1Q>NAIE$1\Q&91.1S+*9A([WNWWWCH'Y]7)ZW='
MT;LEG+?#_?V]03H<[ _AK$M]3<]CGLNA#HH+N55$.Z-UY@8 P3NQ0A;K/V$Y
M"@3OHGJQ8/)VDD$7JP7N_G%2RP?&F<0\U**&7\ O""A87>#!9R$.1SV[I' 9
MPFUKEFFF@)[(4P?+Q=8RA:K]8VL"40%LV =$4/@6'0$,P^,8J\@+>'C_V1YK
M86[8RF(07!EBWHQ(.;)&1-X8VQL':*[)0@@<6G&D/C*<0V^\6+%*&6S#,PE0
M)$O8^OL'YSC:T'P7G]$(V5T4J -S,TNN:$&(VBJI^,,0&.PIY+=X_C?L^\[^
M'9D^F#]QCK&$F:?H<L*;'2YE)]6*0MW^5E8%M,!"FJ1<,NH4<V58A:($-K9?
MG3-8%:Y8T3L^8*V?@3ZYLUQ@G)+97,5CXGGMGB*IB9HLW,[$QB*=.FB/>8%A
MA275T5*1,#"/N3$ZRZZTL!(3GIYAY2)")P77A*+4J6C_+VTR-^6REXB!NR,K
M<4W4]>DVZOHUHJ[[>]NPZP.40)>[K,&1;F.K)('TH>HH"&Y"6W>'V)]&296Q
MF@:7AE*)4OHEJSWH+TPE2C)=HGO'M_7S(KBU^$)#P&YR[B3E"Z=<R:ERMM%*
M)1XW3@"7EO8JO0VM3!5)B!75;&K)ODTMD<'([[#Y'Z W=T(<?HUM0;O"Q?PU
MJHBY.FZ;'F$PS&LUB.C3%(A^CS6(V[3;O])"W>3EHM^?^E-JZOEY:AD'+AQ?
MM;-&H(M71E%TZM1ZA<[L:DR&09UYK7LN?EJ+T70RS_J]+F*.DASP8AEP$T/V
M[QI[6ZHG75T4''?).%$[5L>D5+AOV,GB5ER46!=^0<$FU((;@#9!W2(?/Q:0
MQB##.2>_^F6@+"#;),@V;7,O *2"I*W0]&2)\A7.UGA9-_#8TB4NBX,6,"@L
M99XR: _E$BS/$D>322B:BMIC.K,:H'7RA\/@;.(>FGPF'C9]?+??>V^\O'9&
M$Y2OV=2I+\W9[<E*LH,;WD<9#_53@=Y)E,/&UQDJ3$5E(Z 1!&B"=>+ 2"6W
MCOY>-7A,I00/F?O*Z2M1*/??58MGUT&$HP1SDITM(I),>P,GX&>*<"2".#<^
MS8Y2:GCC5$5D'3-\UAH.'0-EH.I_H%3-9LC-^[JH<?M95FF8;*Q2=*X%*"Q:
M%U:S7+6DY@DGA>OS7ERL*M0ZT?UIEMOKE%\3)%KF0I.J;?=[F(:LHXK"Y(?I
M$A,!3*9&!ZG,9N_6LDP7)6R+P9.A5YS)'&=R^SAOD.V'LLT]L708@Q?PUXV2
MWC@&]GB;M,=L:BMUF+%[N1XP+U)",-:R(Y:C@5(3< ])^0TGEJ=I[*%+4 7G
M14(I??X69!?4E[_X[HAG=L1(+3LABA8\<Y=1B[]DK(.R'W!$,4,F52 9;X02
MR4JI9,E"A?TD>I\D>,5623:1^Z09W)9K@R\]Y]Y0-!*)I)6I.Y?,I;B=+[G,
MV7$6W U]JOM1-F'W!4*>-KU!=B-'81AWE-Y$G2MVBOZ96\6KID.P@$M'LBI;
MMIUBAP/IA5]J[<8719 =E+8^)T'AEI5NYF-I H8$^A!@:M_'?GB\-&7HE<L.
M4%D?_$0)J^ -&5[[EFS+AJD";<E6T\3=C&)8MHKWI U>70,ULQF:UG/-2L;#
MP"M^ D]S"/,PXB'46TIYP%L"T3 Y\JZ;"PT0*;@4D(CPQDQJ@\P(T@_;.N-D
MX3>5(85/*-T/BR'*36%6Z(+^]',K\7 BSIC5C#(5J:4#3$USC9TI%2*3$0%\
M4K;IS5N;J!,O+50>TR!]"Q.<6QN6HCJ(CF+4@0"KX;M11<#+<;U,.*KO!(!5
MPWG$NYHY(M^E[O74[WFBG^.W9\Z$R]=,%D.221W_IF(SWS\6_T>^('('&0Z"
MAAB+F\G!K/M@R\33K>2/KK0.15:3Y8'Y(O#V0C^-Y.U1_U"/E2OU,H,)9LH6
M?-KN-V+6(-L7]&>#!PC>+KL4K4B-@N %<9D5,R_V=&JMY*.QJ5/@FM$UX?,]
M8]H$!%4:DQW!H4;G%-)U@B@GC/?F6CG4?^.=V>G7..,/M\[XK^*,W]\ZX^\B
MRN3CD#>'NZ(9B#.,6>5W49[?8\3-S>;B<'>?!HRWW,MTCD+?G9/U\*.#.S\9
M'R6)<4[VHY_8UIGRMO!U6+F)U<R<\,19RF"924Z>,(07'BW#H*(/#.CYT(:)
MK>F93_XJ6B!=6+,5^:/\NS5FNHJ*":#XMHLIN2&G=.Y$RI$S7MZMV.J_3J]J
M^R:_,P.4[DKD%K/F*L/5'8,7M+U/==R[T1M1.&QO?&<3=(U DXGOG+99.VT(
MRG%QF2J\L=]K[X(ZLJKL#V1[^&9OR% F1H93K&0A1<J])2/E!Y'P1)=J^3E&
MF,&83M%)3_-M*;B<?H.9:SHN"2D3KQB2>!U)#Z*>Q&Z8)G01E"FI7DY& D^
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MQM4>=)99D-T>WQG#Y>M<UP?1&5:@\C:%S=Q(V/<Q3<7MBVD@.1+$);@O)DX
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M1NJ^2J3NR392]T!5Z -K4%DW?<6 B OV"#F2J9UPDZA]RR57K++E&GQMVR?
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MBX@:["H6_""X,QP4-:NT<+9]W?IK^SIS9$N2D,!%=SG-DB_2<^/-1[%&\1[
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M6F2;6_HI%[(+I2=FIU&LQFDRY>9]9)R$:A:L2$VRZ8)(<JT4NJR'@RYA214
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MV;#(,6::0F%?=) !+_F0":A0T=6ID>W1"1\H\UF\S*-9*M7]=0EAX@F21OD
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M]'O_.#F"\_P*-\KS%[N[T=N=7W;B:+2/QQHDP]$OH[CY_O8NO,)W_3;:/_W
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MR74Q1SI5B.37)?F4\),VM%/A]S:1WM0F_ZR]_T'VQ-5,Y2"7=#Q+0D&^(4G
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M4 +:8E,O_IH2B]ETB']X8ON5.Z$;PJ.H#_?U0\\/,9\*[D/=)H96(J%C"=D
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MV]_)1EF\#0X6K,QLONWR-CP]ZSJX-RFHF%OUY_Z$56JZC@\/!N<9[XBLQ(X
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M@R^&Y#1'/J)7AZU: >MWX?-!=$WZ<@)C=F7"^\/60/6E73E\5U&+DNN56:6
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M!2N[$//=?T5SE/]MV#:1EUNCZ66:>OD'4$L#!!0    ( &>'1%1^!V)3_PH
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M>#$M,2YH=&U02P$"% ,4    " !GAT14@/AYT%A8  #2(0( "0
M    @ 'Q% $ 97@T+3,N:'1M4$L! A0#%     @ 9X=$5-&WE'01+0  /WL"
M  P              ( !<&T! &9O<FUS+3%A+FAT;5!+ 0(4 Q0    ( &>'
M1%2'DISL-0,  .P+   1              "  :N: 0!S<FYA+3(P,C$P.3,P
M+GAS9%!+ 0(4 Q0    ( &>'1%1^!V)3_PH  &R'   5              "
M 0^> 0!S<FYA+3(P,C$P.3,P7VQA8BYX;6Q02P$"% ,4    " !GAT14VZ?E
M[U '  "[6   %0              @ %!J0$ <W)N82TR,#(Q,#DS,%]P<F4N
9>&UL4$L%!@     &  8 ;0$  ,2P 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
